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"Many people say that it is the intellect which makes a great scientist. 
They are wrong: it is character." 
 
- Albert Einstein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
Table of Contents 
Abbreviations ............................................................................................................................ 6 
List of figures and tables ........................................................................................................... 8 
1. General Introduction .......................................................................................................... 11 
1.1 Nitric Oxide .................................................................................................................... 11 
1.1.1 Nitric Oxide biosynthesis ............................................................................................. 12 
1.1.2 Intracellular mechanisms of NO action ................................................................... 14 
1.1.3 Vascular effects of NO ............................................................................................... 16 
1.1.4 Multimodal imaging of NO ........................................................................................ 17 
1.2 Arterial wall structure .................................................................................................... 19 
1.3 Thrombosis ..................................................................................................................... 21 
1.4 Carbon dots ................................................................................................................... 23 
1.5 Two-photon laser scanning microscopy (TPLSM) ....................................................... 24 
1.6 Scope of the study ........................................................................................................ 27 
1.6.1 Nitric oxide imaging in the vasculature ................................................................... 27 
1.6.2 Investigation of arginine supplementation and effects of Arginase-1 deficiency 
on vascular NO production (various NOS mediated) during endotoxemia ............... 30 
1.6.3 In vitro thrombus imaging with carbon dot ............................................................ 33 
2. Materials and methods ....................................................................................................... 34 
2.1 Materials ......................................................................................................................... 34 
2.1.1 General equipments .................................................................................................. 34 
2.1.2 Consumables............................................................................................................... 34 
2.1.3 Buffers, Chemical Reagents, Dyes ........................................................................... 34 
2.2 Animal Care and Mouse strains ................................................................................... 35 
2.3 Methods ......................................................................................................................... 35 
4 
 
 
2.3.1 Spectroscopic measurements .................................................................................. 35 
2.3.2 Cytotoxicity assay ....................................................................................................... 36 
2.3.3 Cell cultures and imaging ......................................................................................... 36 
2.3.4 Griess assay .................................................................................................................. 37 
2.3.5 Tissue preparation ....................................................................................................... 37 
2.3.6 Mounting procedure. ................................................................................................. 38 
2.3.7 Wire myography ......................................................................................................... 39 
2.3.8 In vitro thrombus formation ....................................................................................... 40 
2.3.9 Two-photon imaging .................................................................................................. 40 
2.3.10 Two-photon ex vivo NO-production measurements in carotid arteries of 
endotoxemia mouse model............................................................................................... 42 
2.4 Image analysis .............................................................................................................. 42 
2.5 Statistical analysis ......................................................................................................... 44 
3. Results .................................................................................................................................. 45 
3.1. Validation of the NO probe for vascular biology ...................................................... 45 
3.1.1. Cu2FL2E is more sensitive and specific than DAF-2-DA for NO detection ......... 45 
3.2. Visualization-analysis NO metabolism in vitro in endothelial cells .......................... 48 
3.2.1. NO production can be imaged specifically in vitro in endothelial cells with 
Cu2FL2E ................................................................................................................................. 48 
3.3 Visualization of NO synthesis and vasomotor responses in the vasculature ............ 54 
3.3.1 NO production can be imaged and visualised ex vivo in non-precontracted 
murine carotid arteries and aortas with Cu2FL2E. ........................................................... 54 
3.3.2. Time-profile of changes in fluorescence intensity in ECs and SMCs of carotid 
arteries after stimulation ...................................................................................................... 58 
3.3.3. NO production can be imaged and visualized ex vivo in precontracted 
murine carotid arteries with Cu2FL2E ................................................................................. 59 
5 
 
 
3.3.4 Cu2FL2E does not influence the contractile behaviour of carotid arteries after 
pre-contraction. ................................................................................................................... 61 
3.3.5 3D reconstruction of the vessel ................................................................................. 62 
3.3.6 NO-mediated vasomotor response of arteries can be determined at end point 
and correlated with the change in fluorescence intensity ........................................... 63 
3.4. Visualization of NO synthesis and vasomotor response in the carotid artery in wild 
type and Arginase-1 deficient mice ................................................................................. 65 
3.4.1 NO synthesis in normal and endotoxemic carotid artery of wild type mice: 
effect of arginine supplementation .................................................................................. 65 
3.4.2 NO synthesis in normal and endotoxemic carotid artery of Arginase-1 -/- 
mouse (Argfl/fl/Tie2-Cretg/-): effect of arginine supplementation ................................... 69 
3.4.3 In vitro assessment of arginine supplementation on human coronary arterial 
endothelial cells ................................................................................................................... 72 
3.5. In vitro thrombus imaging with carbon dot and TPLSM ............................................. 73 
3.5.1 Structure of the bilabled peptide ............................................................................. 73 
3.5.2 Characterization of fluorescent properties of C-Dot ............................................. 74 
3.5.3 Thrombus imaging with TPLSM and c-dot-TAMRA conjugated A14 peptide 
reveal c-dot and TAMRA as FRET pairs ............................................................................. 75 
4. General discussion – future perspectives ......................................................................... 77 
5. Summary .............................................................................................................................. 83 
6. Zusammenfassung .............................................................................................................. 85 
7. Acknowledgements ........................................................................................................... 87 
8. References ........................................................................................................................... 91 
9. Curriculum Vitae ............................................................................................................... 105 
 
 
6 
 
 
Abbreviations 
ACh               Acetylcholine 
ARG-1           Arginase-1 
C-Dot            Carbon dot 
DAPI              4',6-diamidino-2-phenylindole 
DAF-2-DA     Diaminofluorescein-2-diacetate 
ECs                Endothelial cells 
EDHF              Endothelium derived hyperpolarizing factor 
eNOS   Endothelial nitric oxide synthase 
ECM              Endothelial cell medium 
FRET               Fluorescence resonance energy transfer 
Gd                Gadolinium 
HCAECs        Human coronary artery endothelial cells 
HMVECs       Human microvascular endothelial cells 
HBSS             Hanks balanced salt solution 
iNOS  Inducible nitric oxide synthase 
L-NAME        L-NG-nitroarginine methyl ester 
nNOS  Neuronal nitric oxide synthase 
NA                Noradrenaline 
NO                Nitric oxide 
NOS              Nitric oxide synthase 
PAECs           Porcine aortic endothelial cells 
PBS                Phosphate buffer solution 
PI                   Propidium Iodide 
PE                  Phorbol ester 
7 
 
 
                                                                                                                                Abbreviations  
Q-Dot           Quantum dot 
ROS               Reactive oxygen species 
SMCs            Smooth muscle cells 
SNAP            S-nitroso-N-acetyl-D,L-penicillamine 
TAMRA         Tetramethyl rhodamine  
TPLSM           Two-photon laser scanning microscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
 
List of figures and tables 
Fig. 1 NO: the miracle molecule - 12 
Fig. 2 Intracellular mechanism of NO formation via NOS activation - 15 
Fig. 3 NO signaling pathway - 16 
Fig. 4 Simplified model of an arterial vessel wall - 20 
Fig. 5 Process of thrombus formation in a blood-vessel - 22 
Fig. 6 Carbon dots for imaging - 24 
Fig. 7 Representation of the jablonski diagram - 26 
Fig. 8 Representation of the core of the study - 28 
Fig. 9 Scheme of NO detection by Cu2FL2E in endothelial cells - 29 
Fig. 10 Experimental set up of the prolonged endotoxemia model - 31 
Fig. 11 Scheme of arginine metabolism by endothelial cell by various pathways - 32 
Fig. 12 Schematic representation of the perfusion chamber used to mount isolated   
arteries - 39 
Fig. 13 Two-photon microscopic setup (Leica TCS SP5) - 41 
Fig. 14 (a) Image analysis: Step1 - 43 
Fig. 14 (b) Image analysis: Step2 - 43 
Fig. 14 (c) Image analysis: Step 3 - 44 
Fig. 15 Sensitivity of Cu2FL2E compared with DAF-2-DA - 45 
Fig. 16 Specificity of Cu2FL2E compared with DAF-2-DA for NO and H2O2 - 46 
Fig. 17 Cytotoxicity assay - 47 
Fig. 18 Detection of NO with Cu2FL2E produced by endothelial cells in vitro - 49 
Fig. 19 Griess assay - 50 
Fig. 20 HCAECs with eNOS phosphorylation - 51 
Fig. 21 NO detection in human coronary arterial endothelial cells (HCAECs) with PE - 52 
9 
 
 
                                                                                                               List of figures and tables 
Fig. 22 Detection of NO with Cu2FL2E produced by endothelial cells in vitro with flow - 53 
Fig. 23 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E - 55 
Fig. 24 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E with ACh - 56 
Fig. 25 DAPI staining of SMCs and ECs - 57 
Fig. 26 Detection of NO produced in explanted murine aorta ex vivo using Cu2FL2E in 
aorta - 58 
Fig. 27 Profiles of NO occupancy in SMCs and ECs in carotid artery - 59 
Fig. 28 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E with precontraction - 60 
Fig. 29 Original trace recordings of percentage of relaxation of mouse carotid arteries in 
a vessel myograph - 61 
Fig. 30 3D reconstruction of vessel - 62 
Fig. 31 Functional imaging of NO - 64 
Fig. 32 Effect of SNAP and CuCl2 on integrity of Cu2Fl2E - 65 
Fig. 33 Detection and quantification of NO produced in explanted murine carotid 
arteries (normal) ex vivo using Cu2FL2E for arg supplementation - 66 
Fig. 34 Detection and quantification of NO produced in explanted murine carotid 
arteries (endotoxemic) ex vivo using Cu2FL2E for arg supplementation - 67 
Fig. 35 Functional imaging of NO in endotoxemic arteries - 68 
Fig. 36 Ex vivo NO production measured in carotid arteries of Control and Argfl/fl/Tie2-
Cretg/- mice - 69 
Fig. 37 Detection and quantification of NO produced in explanted murine arg -/- carotid 
arteries ex vivo using Cu2FL2E - 70 
Fig. 38 Detection and quantification of NO produced in explanted murine arg -/- carotid 
arteries (endotoxemic) ex vivo using Cu2FL2E - 71 
10 
 
 
                                                                                                               List of figures and tables 
Fig. 39 Assessment of arginine supplementation on survival of HCAECs using Cu2FL2E - 72 
Fig. 40 Structure of A14 peptide conjugated with TAMRA (indicated with blue box) and 
C-dot (indicated with red circle) at the N-terminal of the peptide - 73 
Fig. 41 Fluorescent characteristics of C-dot - 74 
Fig. 42 Fluorescence from C-dot expressed on fibrin - 75 
Table 1: Mouse strains used in the study - 35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
 
1. General Introduction 
1.1 Nitric Oxide 
In Sir John Vane’s words endothelium is a “marvelous factory”. This endothelium indeed 
opened a major new chapter in cardiovascular physiology. In 1980, Furchgott and 
Zawadzki found that vascular endothelium is indispensable for the vasodilator action of 
acetylcholine in isolated arterial strips or rings (1). Removal of the endothelium 
prevented the relaxant effect of acetylcholine and even led to a contraction. Thus, 
stimulation of the endothelial cells caused the release of a substance, which Furchgott 
named “endothelium derived relaxing factor” (EDRF). This was an “Eureka” moment in 
science as it defined a novel endogenous intercellular signaling system, whose further 
characterization and physiological and pathophysiological consequences were to 
grow exponentially over the years to come. In 1987, EDRF was shown to be nitric oxide 
(NO), as independently pointed out by Moncada and Ignarro (2, 3).  This increasing 
interest in NO led to its nomination as molecule of the year by Science in 1992 (4).  
The fundamental discoveries in NO research led to the awarding of Nobel prize for 
Physiology and Medicine to Robert F. Furchgott, Louis J. Ignarro, and Ferid Murad in 1998 
(5). NO is now known to serve a multitude of physiological roles throughout mammalian 
cardiovascular systems, let alone in other systems and other organisms. Nitric oxide 
discovery was indeed a landmark in biology. This simple, free radical gas mediates 
various biological phenomena and seems to regulate diverse processes. NO is involved 
in various vascular phenomena such as vascular relaxation (2, 3), inhibition of platelet 
adhesion and aggregation (6, 7, 8, 9), and inhibition of vascular smooth muscle cell 
mitogenesis (10). The bioavailability of nitric oxide is decreased in many cardiovascular 
complications, which contribute to vasospasm, thrombus formation, and intimal 
thickening, ultimately leading to ischemia and infarction.  Prevention of identified 
predisposing conditions is crucial, and hence, NO is an important molecule to study in 
this perspective. 
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Fig.1 NO: the miracle molecule. Left: Flow chart of many benefits of NO (adapted from 
www.whatisxtremeno.net), Right: Science magazine’s cover page (1992) displaying NO 
as the “molecule of the year” (adapted from Koshland Jr. Science 1992).                
 
1.1.1 Nitric Oxide biosynthesis 
Shortly after 1987, the amino acid L-arginine was found to be the substrate for 
endogenous NO synthesis (11). NO synthase (NOS) was identified as the enzyme system 
responsible for the conversion of L-arginine to NO (11). NOS exists in three distinct 
established isoforms; n-NOS (originally identified as constitutive in neuronal tissue, also 
known as type I NOS), i-NOS (originally identified as being inducible by cytokines or 
bacterial lipopolysaccharide [LPS] in macrophages and hepatocytes, also known as 
type II NOS) and e-NOS (originally identified as constitutive in vascular endothelial cells, 
also known as type III NOS). All three NOS isoforms share similar, if not identical, cofactor  
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and prosthetic group requirements and they all utilize L-arginine as the substrate for NO 
generation. The various NOS isoforms are distributed in different cells and tissues. Along 
with these differences in tissue or cellular origin, the three NOS isoforms do differ 
significantly with regard to their biophysical properties and mechanisms of physiological 
regulation. The constitutive enzymes (cNOS (nNOS and eNOS), [also known as NOSI and 
NOSIII]) were originally described as being Ca2+ and calmodulin dependent (12). eNOS 
is responsible for the NOS activity of vascular endothelium in blood vessels of all sizes                                                                                                                
and types (i.e. arteries, arterioles, capillaries, venules, and veins), in different tissues and 
organs (eg. heart, brain, lung, liver, and kidney) and in various species (13). However, 
eNOS is not uniquely expressed by endothelial cells, but is also constitutively expressed in 
megakaryocytes, platelets, T-cells, erythrocytes, cardiomyocytes (14), epithelial cells, 
and rat hippocampus (15).  nNOS has a widespread distribution in the central and 
peripheral nervous system (16), but has also been detected in non-neuronal cell types, 
such as rhabdomyocytes, epithelial cells, mast cells, and neutrophils (15). It is widely 
expressed in different tissues. The high activity of nNOS in brain and skeletal muscle, 
plays an important role in physiological neuronal functions. It is also an integral player in 
various neurological disorders in which excessive NO production leads to neural injury 
(17). There are two basic pathways for the stimulation of cNOS, both of which involve 
calcium ions from subsarcolemmal storage sites. First, forces acting on the vascular 
endothelium generated by blood flow cause release of calcium and subsequent cNOS 
activation. Therefore, increases in blood flow stimulate NO formation (flow-dependent 
NO formation). Second, endothelial receptors for a variety of ligands stimulate calcium 
release and subsequent NO production (receptor-stimulated NO formation). Included 
are receptors for acetylcholine, bradykinin, substance-P, adenosine, and many others 
vasoactive substances.  
The inducible enzyme iNOS [also known as NOSII] is clearly different from cNOS as it is 
fully active in the absence of Ca2+ or calmodulin. Various cell types and tissues that are 
exposed to cytokinines (eg, tumor necrosis factor-alpha [TNF-alpha], interlukin-1 [IL-1] or 
bacterial products [eg, endotoxin or LPS] induce iNOS. They are also expressed in                                                                                                          
certain cells/tissues such as the mouse ileal mucosa (18), human airway epithelium (19), 
and human B lymphocytes (20). The main characteristic of iNOS is that it releases  
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large amounts of NO continuously; the amount released per unit of time from fully 
activated macrophages is a thousand times higher than that released from NOS in 
endothelial cells. These high concentrations of NO are cytostatic and cytotoxic on 
parasitic microorganisms and tumor cells. Consequently, NO is an essential component 
of the nonspecific immune defense system (21, 22, 23). 
 
1.1.2 Intracellular mechanisms of NO action 
NO is a unique messenger. Being uncharged, NO is soluble both in water and lipid and 
can diffuse freely across membranes. When it reaches the bloodstream, most NO is 
quickly bound to hemoglobin and converted to nitrate. After conversion to nitrate it is 
eliminated in the urine with a half life of few hours (24). However, NO itself has a half life 
of few seconds in solutions in vitro and its biological half life is in the order of few minutes 
(25). NO diffuses out of the cell that generates it into the target cells, where it interacts 
with specific molecular targets. The best characterized receptor of NO is iron, contained 
in certain proteins in heme group or as an iron-sulphur complex. On NO binding to the 
iron in the heme group of soluble guanylate cyclase (sGC), the enzyme is activated 
(26). The binding of NO to sGC results in the conversion of guanosine tri-phosphate (GTP) 
to cyclic guanosine mono-phosphate (cGMP). Subsequently, the increase in cGMP 
activates other cellular processes, thereby acting as a second messenger, activating 
cGMP-dependent protein kinase, which decreases cytosolic Ca2+ concentration and 
modulates ion channel function leading to inhibition of platelet activity or relaxation of 
vascular smooth muscle cells. NO also acts independent of the sGC/ cGMP system, 
such as activation of Ca2+ dependent K+ channels in vascular smooth muscle cells to 
produce hyperpolarization and relaxation (27). Thus, by both sGC-dependent and sGC-
independent mechanisms, NO  not only dilates blood vessels, but also inhibits platelet 
function, inhibits stimulated neutrophils adhesion, and has antimitogenic effects in 
vascular smooth muscle cells. 
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Fig.2 Intracellular mechanism of NO formation via NOS activation (adapted from Lassila 
2000, www.ethesis.helsinki.fi) 
 
Endogenous production of NO by native and cultured endothelial cells in response to 
shear stress is associated with only a transient and minimal increase in calcium ion. In the 
absence of extracellular Ca2+ and in the presence of a calmodulin antagonist, shear 
stress stimulates a continuous production of NO (28). The ability of the EC to sense shear 
stress involves an array of signaling pathways and cellular components, including G 
proteins, caveolae, integrins and the cytoskeleton, which may all participate in the 
mechanotransduction that lead to the activation of eNOS. Several agonists can induce 
the production of nitric oxide. Simultaneous measurements of calcium and NO in 
bradykinin stimulated ECs in vitro reveal that a transient increase in calcium was rapidly 
followed by an increase in NO that outlasted the calcium transient (28). VEGF is a 
potent vascular EC-specific mitogen that stimulates EC proliferation, microvascular 
permeability, vasodilation and angiogenesis (29). Stimulation of beta-adrenoceptors on 
vascular SMCs results in vasorelaxation, through adenylate cyclaseactivation and a 
consequent increase in cyclic adenosine momophosphate (cAMP) intracellularly (12). 
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1.1.3 Vascular effects of NO 
Constitutive NOS isoforms are regulated by Ca2+ via the Ca2+-binding protein 
calmodulin. Due to Ca2+ influx into the cell, this Ca2+-calmodulin complex is formed, 
which then binds constitutive NOS and most likely displaces the enzyme from its location 
to caveolae in the plasma membrane; which leads to activation of NOS and hence, 
increase in NO level (30, 31). Phosphorylation also plays a regulatory role in the activity 
of constitutive NOS. In comparison to constitutive NOS, iNOS activity is regulated 
primarily via the induction of de novo enzyme protein synthesis. The availability of 
substrate and cofactors (most notably BH4) also play a role in iNOS regulation in 
macrophages and smooth muscle (21, 22, 23), as in constitutive NOS. NO derived from 
the constitutive NOS subtypes is involved in the maintenance of vascular tone and  
 
 
 
 
 
 
 
 
 
 
Fig.3  NO signaling pathway. A classic arginine-nitric oxide synthase-nitric oxide synthesis 
pathway highlighting the multiple levels of this pathway (adapted from Zuckerbraun et 
al. Cardiovasc Res 2011). Activation of eNOS in ECs involves an array of signaling 
pathways and cellular components. Several agonists can induce the production of 
nitric oxide. The binding of NO to sGC in SMCs results in the conversion GTP to cGMP. 
Subsequently, the increase in cGMP activates other cellular processes, 
17 
 
 
                                                                                                                1. General Introduction 
neurotransmission, its physiological concentrations may be under stricter regulation than 
that of NO derived from iNOS which is made in large quantities as a cytotoxic agent.  
Vascular actions of NO include direct vasodilation (flow mediated and receptor 
mediated), indirect vasodilation by inhibiting vasoconstrictor influences (by inhibiting  
angiotensin II and sympathetic vasoconstriction), anti-thrombotic effect (inhibits platelet 
adhesion to the vascular endothelium), anti-inflammatory effect (inhibits leukocyte 
adhesion to vascular endothelium), anti-proliferative effect (inhibits smooth muscle 
hyperplasia) and scavenging of superoxide anion.  
Impaired NO production and bioavailability results in causing thrombosis due to platelet 
aggregation and adhesion to vascular endothelium, vasoconstriction (coronary 
vasospasm, elevated systemic vascular resistance), inflammation due to upregulation of 
leukocyte and endothelial adhesion molecules, and also, vascular hypertrophy and 
stenosis. These abnormal NO availability conditions are associated with cardiovascular 
complications like hypertension, diabetes, obesity, atherosclerosis, dyslipidemia, heart 
failure etc. 
 
1.1.4 Multimodal imaging of NO 
NO governs a myriad of physiological and pathophysiological processes. NO is an 
important participant in various vascular diseases. Noninvasive imaging of NO or NOS 
can provide new insights in understanding these diseases and facilitate the 
development of novel therapeutic strategies. An imaging platform integrates and 
assimilates various techniques for visualization of NO with better spatial resolution and 
sensitivity. To this end, the most important imaging techniques in application are optical 
imaging (fluorescence and chemiluminescence), electron paramagnetic resonance 
(EPR) imaging, and magnetic resonance imaging (MRI).                                                                                                        
Fluorescence imaging of NO requires various agents for fluorescent NO detection that 
include: diaminonapthalene (32, 33, 34), dichlorofluorescin (35, 36), iron-based sensor 
(37), cytochrome C based sensor (38), cobalt complex (39, 40), fluorescent nitric oxide 
chelotropic traps (FNOCTs) (41, 42), diaminofluoresceins (43), diaminorhodamines (44),  
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diaminoanthraquinone (45), porphyrin based sensors, copper-based compounds (46, 
47), FRET-based NO sensors (48), and nanoengineered sensors (49). All these 
compounds exhibit certain advantages and certain disadvantages, consequently 
limiting their application in various systems. Diaminofluoresceins (DAFs) are the most 
extensively used agent for NO imaging. These compounds react with NO in the 
presence of oxygen to form the fluorescent products quantitatively in an aqueous 
medium, even under physiological conditions. However, there are serious limitations for 
using DAFs. They only react with NO in the presence of oxygen, which is not an ideal 
condition to study interplay of NO in various conditions (like hypoxic tumor etc.). Also, 
they are not specific for NO and react with oxidized NO products rather than with NO 
itself, which may not truly reflect the status of NO in some diseases. Certain nitrogen-
containing radicals or reducing agents can also cause fluorescence enhancement of 
these compounds. Hence, these compounds are not highly selective and exclusive for 
NO imaging, and thus are not the best choice for measurement of endogenous NO 
formation. However, the latest intervention with copper-based compounds looks 
promising for future application in terms of specificity and sensitivity. The stability and 
toxicity aspects are to be optimized further for potential application in vivo. In the 
present study, we evaluated the feasibility and characteristics of a specific, cell-
trappable, copper-based fluorescent NO probe (Cu2FL2E) for vascular NO analysis both 
in vitro and ex vivo. Cu2FL2E, developed by McQuade L.E. et al. (47), has highly 
desirable properties in comparison to conventional fluorescent NO probes. The Cu2FL2E 
probe is non-toxic and readily internalized by cells in vitro. Moreover, it reacts with NO 
directly and specifically rather than with its oxidation products. Upon reaction of 
Cu2FL2E with NO, Cu(II) is reduced to Cu(I) with concomitant formation of highly 
fluorescent, N-nitrosated FL2E-NO (46, 47). These characteristics of Cu2FL2E make it a 
useful intracellular sensor for NO. In terms of high spatial resolution, high sensitivity, and 
experimental feasibility, fluorescence imaging techniques still stand superior to other 
imaging modalities. We establish that Cu2FL2E is a valuable tool for direct and specific 
imaging and visualization of NO in ECs in vitro and, in conjunction with TPLSM, ex vivo in 
intact vessels with high spatiotemporal accuracy.  
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Chemiluminescence imaging of NO is limited by its low specificity and time consuming 
procedure. EPR is a very powerful imaging tool in NO research, but the heavy 
instrumentation, high cost, small sample size, and the potential toxicity of the spin 
trapping agents are the major roadblocks for future clinical applications. Despite good 
resolution of MRI, its measurement is questionable due to its low sensitivity. Other 
imaging techniques like ultrasound, time-resolved photoelectron imaging, Hb spectral 
alteration imaging, laser induced fluorescence detection, and calcium amplification 
imaging have been used for NO detection. The future of molecular imaging, based on 
multimodal imaging approach may provide more accurate information on NO 
detection like EPR-CT (50), EPR-MRI, EPR-cheminluminescence (51), and PET/MRI (52, 53) 
imaging have been attempted, but further research/optimization is necessary for its 
potential successful application. 
 
1.2 Arterial wall structure 
The arterial wall of murine large arteries is anisotropic, multi-storey, and non-linearly 
elastic. It consists of three different layers; tunica intima, tunica media, and tunica 
adventitia. The tunica intima or inner layer is relatively thin and mainly consists of the 
endothelium (a single layer of endothelial cells) that lines the vessel lumen, underlying 
connective tissue (the basal lamina), and the internal elastic lamina. Endothelial cells 
monitor and regulate many processes, such as vasoconstriction and vasodilation by 
releasing regulatory factors, permeability to specific molecules, and in case of 
inflammation, capturing and allowing trans- and paracellular migration of inflammatory 
cells (54). The luminal side of endothelial cells is covered by a matrix of proteoglycans 
and glycoproteins called the glycocalyx. This matrix also regulates vascular permeability 
and may induce mechanotransduction (55). The basal lamina connects the endothelial 
cells to the vascular wall; it is a structure of extracellular matrix components such as 
collagen. Collagen is a fibrillar protein that provides the strength of the vascular wall. 
The internal elastic lamina separates the tunica intima from the tunica media. It consists 
of elastin, an extracellular matrix protein that provides the elasticity of the vascular wall. 
The tunica media or medial layer primarily consists of several concentric layers of  
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helically arranged vascular smooth muscle cells. The number of layers depends on size 
and type of the artery. The vascular smooth muscle cells are separated by fibers of 
extracellular matrix (collagen, elastin). Interposed between these layers of vascular 
smooth muscle cells are intermediate elastic laminae (the number of intermediate 
laminae again depends on the size and type of the artery) (56). The main function of 
the tunica media is control of vascular tone. Moreover, the vascular smooth muscle cells 
are the cellular source of the extracellular matrix. The external elastic lamina (EEL) is the 
most outer elastic laminae of the tunica media and separates it from the tunica 
adventitia; it is composed of many elastin fibers that form a finely woven structure. The 
tunica media predominantly determines the mechanical properties of the arterial wall. 
The tunica adventitia is the outer most layer of the arterial vessel wall and its basal 
structure consists of collagen and elastin fibers.  These fibers allow the arteries to stretch 
and to prevent overexpansion due to the pressure that is exerted on the walls by blood 
flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4  Simplified model of an arterial vessel wall. The number of vascular smooth muscle 
cell layers and intermediate elastic laminae is dependent on type of artery and species. 
Note the fenestrations (white) in the internal elastic layer (adapted from R.T.A. Megens, 
Maastricht 2008, ISBN 978-90-9022535-7). 
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In between these fibers, fibroblast-like cells and vasomotor nerves are present. In the 
tunica adventitia of large arteries with a vessel wall that is too thick to be solely 
nourished by diffusion, a network of branched small blood vessels or vasa vasorum (57) 
is present that provides metabolites and oxygen to the tunica adventitia and abuminal 
parts of the tunica media. The vessel walls of various large arteries have a number of 
structural features in common although structural variations between comparable 
arteries can be considerable. Note that thickness, detailed structure, and function of 
these three tunicae strongly depend on total diameter, type of blood vessel, and 
species.  
Based on their diameter and location, large arteries may be classified as elastic arteries 
(largest arteries) or muscular arteries (medium sized arteries). Elastic arteries are located 
directly downstream of the heart where blood is transported under high (pulsating) 
pressure. The vessel wall of elastic arteries is thick and elastic, and has a buffering 
function reducing the pulsations of blood flow. Muscular arteries are located more 
closely to organs and tissues and mainly have a conductive function and control the 
affluence of blood to the various organs (56). The vessel wall of muscular arteries is 
thinner and their diameter (and, hence, resistance) is controlled by contracting or 
relaxing the vascular smooth muscle cells in the tunica media (56). 
 
1.3 Thrombosis  
Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel, obstructing 
the flow of blood through the circulatory system. Thrombus formation is the pathological 
hallmark of cardiovascular events such as myocardial infarction and stroke. Normal 
blood vessels are lined by a continuous layer of endothelium. When the lining is 
disrupted, subendothelial elements, such as extracellular collagen, are exposed to the 
circulation. Blood platelets draw a sharp distinction between endothelium and 
subendothelium. This distinction governs platelet function, keeping the surface of normal 
vessels free of platelets while encouraging platelet deposition on exposed 
subendothelium. Depending on the vascular insult, attached platelets initiate either  
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normal (i.e. haemostatic) or abnormal (i.e. thrombotic) events. For example, platelet 
plugs at sites of vascular injury limit blood loss (haemostasis), while platelet masses on 
diseased/ atherosclerotic vessels impair blood flow (thrombosis) and contribute to 
myocardial infarction and stroke. When platelets are activated, they acquire enhanced 
capacity to catalyze interaction between activated coagulation on factors (58, 59). 
These factors circulated in the form of inactive precursors (zymogens). Rupture of the 
atherosclerotic plaque leads to activation of the coagulation cascade: each zymogen 
is converted into an activated coagulation factor, which in turn activates the next 
zymogen in the sequence. 
 
Fig. 5 Process of thrombus formation in a blood-vessel (adapted from Bayer Pharma AG, 
www.thrombosisadviser.com) 
This process culminates in the generation of thrombin, an enzyme that converts the 
soluble protein fibrinogen to insoluble fibrin. This is followed by cross-linking of fibrin fibers 
under the influence of activated factor XIII forming a stabilized blood clot. Alpha2-
antiplasmin is also cross-linked to fibrin under the influence of activated factor XIII,  
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making a clot more resistible to fibrinolysis. Eventually, over the course of hours, a 
stabilized clot develops consisting of activated platelets, erythrocytes, and leucocytes, 
in a matrix of cross-linked fibrin. This coagulation cascade gives rise to many molecular 
targets of thrombosis. Fibrin is perhaps the easiest target within a clot, and has been 
used in several studies. Later in this thesis, an alpha2-antiplasmin based agent is 
described which was used to target fibrin and visualize thrombus formation with two-
photon microscopy (60, 61). 
 
1.4 Carbon dots 
Carbon, an element of prehistoric discovery, is very widely distributed in nature. It is the 
sixth most abundant element in the cosmos, yet its abundance in the earth’s crust does 
not even make it among the top ten elements on our planet.  Carbon is a very special 
element because it plays a dominant role in the chemistry of life. With the revolutionary 
discoveries of the C molecule and carbon nanotube, carbon nanotechnology has 
become the building block of the entire field of nanotechnology. Whether it is 
deoxyribonucleic acid (DNA) or synthetic polymers, all are based on carbon 
backbones. Nature has been doing remarkably well by systematically organizing matter 
at nanometer-length scale in biological systems. It exhibits a unique property to form a 
wide range of structures. It is the chemical genius of carbon that it can bond in different 
ways to create a range of structures with entirely different properties.  
Sun and colleagues prepared the carbon nanoparticles by laser ablation from a 
carbon target in the presence of water vapour. The resulting particles were around 5 
nm in diameter. The team treated the particles with nitric acid solution before 
passivating their surfaces by adding a polymer coating (62).  
The polymer consisted of diamine-terminated oligomeric poly(ethylene glycol) 
PEG1500N orpoly(propionylethyleneimine-co-ethyleneimine(PPEI-EI). When illuminated, the 
coated carbon nanoparticles photoluminesced, emitting light with visible and near-
infrared wavelengths. These photoluminescent carbon dots (C-Dots) have attracted 
much recent attention for their promising application in the field of biomedical imaging,  
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as they have been found strongly two-photon active. Metal based nanoparticles have 
limited application in biological application for it raises serious concern on health and 
environment of the community.  
Therefore, cDots are benign alternative, as carbon is hardly considered intrinsically toxic. 
On the application part, C-dots have been exploited successfully for in vitro and in vivo 
imaging (62, 63). cDots have been shown to be biocompatible, and non-toxic in vivo, 
while its strong fluorescent characteristics are not affected in vivo. 
 
 
 
 
 
 
 
 
 
Fig. 6 Carbon dots for imaging. (a) The C-Dot structure; (b) AFM topography image of C-
Dots on mica substrate, with the height profile along the line in the image (adapted 
from Li Cao et al. J Am Chem Soc. 2007)  
 
1.5 Two-photon laser scanning microscopy (TPLSM) 
The main theory of TPLSM came in 1931 from Maria Goppert-Mayer when she explained 
in her doctoral dissertation the concept of simultaneous absorption of two photons at a 
low energy state and emission of one photon at a higher energy state by a fluorophore 
in a single quantum event (64, 65). Later, in 1990, two-photon laser-scanning microscopy  
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(TPLSM) was developed by Webb and colleagues (66). Since the probability of two-
photon absorption depends on the square of the intensity of the excitation light, 
excitation only occurs in a very small volume at focal position of the microscope (67). 
Therefore, out of focus absorption and excitation, as in normal or confocal fluorescence 
microscopy, are absent and as a result, emitted photons always originate from the focal 
position and thus are independent of scattering. Each photon carries approximately 
half the energy necessary to excite the molecule. An excitation results in the subsequent 
emission of a fluorescence photon, typically with a higher energy than either of the two 
excitatory photons. The probability of the near-simultaneous absorption of two photons 
is extremely low. Therefore a high flux of excitation photons is typically required, usually a 
femtosecond laser. The most commonly used fluorophores have excitation spectra in 
the 400–500 nm range, whereas the laser used to excite the two-photon fluorescence 
lies in the ~700–1000 nm (infrared) range. If the fluorophore absorbs two infrared photons 
simultaneously, it will absorb enough energy to be raised into the excited state. The 
fluorophore will then emit a single photon with a wavelength that depends on the type 
of fluorophore used (typically in the visible spectrum). Because two photons are 
absorbed during the excitation of the fluorophore, the probability for fluorescent 
emission from the fluorophores increases quadratically with the excitation intensity. 
Therefore, much more two-photon fluorescence is generated where the laser beam is 
tightly focused than where it is more diffuse. Effectively, excitation is restricted to the tiny 
focal volume (~1 femtoliter), resulting in a high degree of rejection of out-of-focus 
objects. This localization of excitation is the key advantage compared to single-photon 
excitation microscopes, which need to employ additional elements such as pinholes to 
reject out-of-focus fluorescence. Due to this excitation process, TPLSM possesses some 
interesting features; enhanced depth penetration, good optical sectioning, good 
resolution in three dimensions, and strong reduction of photobleaching, photo-damage, 
and photo-toxicity. This combination of features makes TPLSM better than other 
microscopic techniques for imaging of structures which are located deep in (scattering) 
tissues. The studies described in the present thesis were performed in order to visualize a 
variety of morphological and functional properties of healthy and diseased large 
arteries of mice using TPLSM. 
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Fig. 7  Representation of the jablonski diagram; showing one photon (a) and two 
photon (b) excitation. (adapted from Palikaras, K. and Tavernarakis, N. Multiphoton 
Fluorescence Light Microscopy. eLS , 2012) 
 
However, TPLSM has also some drawbacks. (1) TPLSM is an expensive technique (68) 
and not yet routinely used for biological studies since it requires specific expertise for 
effective application (68, 69). (2) Due to the longer wavelengths used for excitation light 
(68), the spatial resolution in TPLSM is somewhat reduced when compared with CLSM. 
However, this only holds for imaging at shallow depths in the sample. Indeed, the size of 
the excited focal volume in TPLSM does increase with increasing depths (due to 
scattering and the consequent increase of the excitation light intensity), but the 
resolution of TPLSM deteriorates far less with increasing depth than that of CLSM (70). (3) 
Although photo-damage and photo-toxic effects are reduced, TPLSM can have 
negative consequences for the viability of biological samples (71, 72). Two photon 
excitation may cause heating of the sample, impaired cellular reproduction, oxidative 
stress, or apoptosis-like cell death. In order to avoid these effects, non-destructive 
imaging of live samples is limited to an optical window, dependent on the applied 
fluorophores, laser intensity, detector sensitivity, and the sample (72). 
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1.6 Scope of the study 
NO is a tricky molecule to study due to its short half-life of a few seconds and high 
diffusibility. Serious limitation of current research methods is the ability to visualize the 
spatial and quantitative formation of NO. The available chemical assays and methods 
detect NO indirectly. Dearth of specific and selective tools to study NO directly is a 
challenge. However, in order to understand the role of NO in biology and medicine, its 
direct detection is indispensable. 
Our imaging platform integrates and assimilates various techniques for visualization of 
NO with better spatial resolution and sensitivity.  
The studies described in this thesis were performed to obtain more knowledge on the 
vascular structural production and functional analysis of NO in vasculature with 
emphasis on specific determination of NO with high spatial and temporal resolution.  A 
novel fluorescent imaging technique is described to visualize vascular nitric oxide 
production at an unprecedented level. The second part of the thesis deals with 
translation of this research findings into a model of cardiovascular complication and 
illustrates the applicability of our technique in a disease system. In many cardiovascular 
diseases, the capacity of the L-arginine/NO system is decreased, an obvious 
therapeutic measure would be the pharmacological substitution of NO or stimulation of 
the L-arginine/NO system.  
In the final part of this thesis, a novel carbon dot nanoparticle conjugated peptide is 
described that aids in thrombus imaging, showing future potential application. This thesis 
deals with two-photon microscopy in the forefront of technology to unravel the latest 
know-how in the vasculature.  
 
1.6.1 Nitric oxide imaging in the vasculature 
Endogenously produced vascular nitric oxide (NO) affects important biological 
processes such as platelet and leukocyte adhesion, smooth muscle cell (SMC) migration 
and endothelial regeneration in blood vessels (3, 73, 74, 75). Regulation of blood flow 
through induction of vasodilation is a major function of endothelial-derived NO. Cellular  
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NO is produced by three different enzymes (i.e. iNOS, eNOS, nNOS) (75), of which 
endothelial nitric oxide synthase (eNOS) is specifically expressed in endothelial cells 
(ECs) and is essential for the physiological NO (order of nanomolar range) (56, 76) 
production in healthy blood vessels. In response to increased shear stress, eNOS is 
activated in the endothelium (74, 75), with subsequent production of NO. NO then 
diffuses to the neighboring SMCs, where it actively induces vasodilation through SMC 
relaxation and subsequently increases vessel lumen diameter (3, 56) and blood flow.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Representation of the core of the study (marked in green circle): Scheme 
illustrating NO production in the vasculature and other molecular and cellular 
atherogenic players (from Robin P. Choudhury et al. Nature Reviews Drug Discovery 3, 
913-925, November 2004). Illustration of processes of atherogenesis ranging from pre-
lesional endothelial dysfunction (left) through monocyte recruitment to the 
development of advanced plaque complicated by thrombosis (right). Various 
components shown here can be potential useful imaging targets. 
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Abrogation of NO production in dysfunctional endothelium is involved in numerous 
chronic cardiovascular diseases such as hypertension and atherosclerosis (75, 76), but 
also plays an important role in acute diseases such as sepsis. 
The direct and specific detection of NO in living cells and tissues is a major hitherto 
unmet requirement for investigating the role and (sub) cellular NO constitution in various 
disease processes.  
Ongoing research has been aimed at detecting and quantifying physiological NO 
levels (74), however the high diffusibility and short half-life (3-16 sec.) of NO complicate 
real time detection (77, 78, 79). Hence, little is known about the time course and 
diffusion profile of endogenously produced NO.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Scheme of NO detection by Cu2FL2E in endothelial cells, showing the probe is 
trapped in the cell via hydrolysis of the pendant ester groups by intracellular esterases to 
give Cu2FL2A since the ester (E) is hydrolyzed to the acid (A). (Ghosh et al. submitted) 
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Several chemical methods are available to measure the oxidation products of NO, such 
as nitrite or nitrate but the detection of NO itself has proved challenging. We therefore 
used fluorescent probe-based imaging methods to study NO dynamics. The high 
sensitivity, spatial resolution, and experimental feasibility make fluorescent-based 
methods the preferred imaging modality (76, 77, 78). An added advantage of this 
strategy is that structural and functional imaging can be combined simultaneously (56, 
80). 
Determining the spatiotemporal relationship between vascular anatomy and NO 
production is crucial to unravel the role of NO in vascular pathologies. To address NO 
synthesis in vessel wall, two-photon laser scanning microscopy (TPLSM) was used, which 
enables fluorescent imaging of Cu2FL2E with subcellular resolution, large penetration 
depth, and optical sectioning (to obtain 3D reconstructions of the tissue) (56, 80).  
We establish that Cu2FL2E is a valuable tool for direct and specific imaging and 
visualization of NO in ECs in vitro and, in conjunction with TPLSM, ex vivo in intact vessels 
with high spatiotemporal accuracy. We also show that this methodology allows relative 
quantification of NO and exploration of NO-mediated vasomotor response ex vivo. The 
Cu2FL2E probe offers unique possibilities for studying the spatial and temporal synthesis 
of NO in vascular biology and pathology. 
 
1.6.2 Investigation of arginine supplementation and effects of Arginase-1 
deficiency on vascular NO production during endotoxemia 
Endothelial dysfunction, associated with imbalance in NO metabolism plays a crucial 
role in the development of endotoxemic conditions, such as in sepsis (81, 82, 83, 84). A 
diminished NO bioavailability caused by depressed de novo synthesis or aggravated 
NO turnover is regarded key to this endothelial dysfunction (85). Under normal 
conditions, endothelial NO is mainly generated by the endothelial nitric oxide synthase 
(NOS3; eNOS) mediated conversion of L-arginine to L-citrulline. The NOS3 activity is 
critically controlled by its substrate (L-arginine) availability. During pathological 
conditions such as inflammation, L-Arginine concentrations significantly decrease and a  
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diminished NO bioavailability in the microcirculation becomes evident (81, 86, 87). 
Inhibition (88) or uncoupling (89) of NOS3, impaired arginine de novo synthesis, or 
reduced cellular arginine uptake may all depress NOS3 derived NO production (87, 90) 
and as such vascular function. Another important contributor to depressed NOS3 
derived NO is endotoxemia, as endotoxemia downregulate NOS3 and upregulates the 
inflammatory NOS (NOS2; iNOS), which competes with NOS3 for L-arginine (91, 92, 93). 
iNOS can produce excessive amounts of NO during endotoxemia, which contributes to 
the decreased arterial pressure and abnormal blood flow leading to cardiovascular 
complications (84, 94, 95). Simultaneously, eNOS-mediated NO production is decreased 
due to endotoxemia–induced eNOS downregulation, coupled with decreased 
substrate availability (88). 
 
 
 
 
 
 
 
 
 
Fig. 10 Experimental set up of the prolonged endotoxemia model. Mice were fitted with 
a jugular vein cannula at t = 0 days. After 4 days (t = 4 days) an 18 hours continuous 
infusion with lipopolysaccharides (LPS) was started, which was combined during the last 
6 hours with an infusion of Arginine (Arg) or an isonitrogenous quantity of the placebo 
Alanine (Ala)(modified from Wijnands KAP et al. PLoS ONE 2012). 
 
An obvious approach would be pharmacological substitution of L-arginine. However, it 
has been demonstrated that L-arginine supplementation in prolonged endotoxemia 
and sepsis failed to increase the intracellular NO production despite increased arginine 
plasma availability (96, 97, 98, 99, 100).  Thus, to investigate whether arginine 
supplementation during an ongoing endotoxemia rescues the eNOS-derived NO  
        TPLSM  
   imaging of NO 
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production in endothelial cells is an interesting approach. Also, enhanced arginine 
catabolism by arginase-I (101, 102) significantly contributes to the arginine-NO 
deficiency found in inflammation and endotoxemia (83, 102, 103). Intriguingly, arginase-
I mediated regulation of arginine availability subsequently affects NOS (2 and 3) activity 
and related NO synthesis in endothelial cells (NOS3) (102, 104, 105, 106) by depleting the 
arginine concentration. Reciprocally, lowering and depletion of total arginase-I activity 
significantly enhances NOS-related NO production during inflammation (104, 107, 108, 
109, 110). This critical interrelation between arginase-I, substrate availability and NOS 
activity makes modulations of arginase-I activity an interesting therapeutic option for 
treating inflammatory diseases related to impaired NOS3 dependent NO production.   
 
 
 
 
 
 
 
             
Fig. 11 Scheme of arginine metabolism by endothelial cell by various pathways; 
showing arginine metabolism by endothelial eNOS to convert arginine to citrulline, 
which then by use of ASS enzyme converts to arginine to be used in urea or ornithine 
cycle. 
 
To demarcate the therapeutic potential of selective arginase-I modulation in 
enhancing NOS3 associated NO synthesis and in counteracting vascular dysfunction 
during inflammation, a prolonged endotoxemia model was inflicted in endothelial / 
hematopoetic arginase-I deficient knockout mice (111) and Cu2FL2E-TPLSM approach 
was used to address these issues. 
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1.6.3 In vitro thrombus imaging with carbon dot 
The convergence of nanotechnology and bioimaging opens the door to a revolution in 
molecular imaging. Medical imaging has evolved from a marginal role in healthcare to 
become an essential tool of diagnostics over the recent years. The convergence of 
nanotechnology and medical imaging opens the doors to a revolution in molecular 
imaging. Molecular imaging is based on the molecular and cellular fingerprints of the 
disease, requiring disease-specific molecular targets as well as target-specific 
nanoparticles. The remarkable properties of nanoparticles have resulted in their use as 
an alternative to both small-molecule and protein fluorophores in innumerable 
biological applications. In this study, a Factor XIII specific ligand (peptide A14) coupled 
to cDots are being used which will help to visualize thrombi with two-photon 
microscopy. This novel bimodal alpha2-antiplasmin-based contrast agent (peptide A14) 
binds to fibrin exposed during thrombus formation and visualization can be done with 
two-photon microscopy with intense fluorescence signal resulting from the 
nanoparticles at the target. Activated factor XIII (FXIIIa) plays an important role in 
regulating the resistance of thrombi against fibrinolysis. Upon activation, FXIII becomes 
capable of cross-linking fibrin alpha and gamma chains of neighboring fibrin molecules, 
providing stability of the thrombus. Moreover, FXIIIa covalently cross-links alpha2 
antiplasmin, a key inhibitor of plasmin-mediated fibrinolysis, to fibrin (61) showed that 
contrast agent based on alpha2- antiplasmin (peptide A14) provides specific 
visualization of fresh thrombi. cDots are potentially nontoxic and smaller as compared to 
other frequently used nanoparticles like heavy metal-based quantum dots. Therefore, 
they hold good promise for clinical translation. In our case, the peptide was bilabeled 
with TAMRA for control of cDot efficacy. Imaging was performed by TPLSM.  
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2. Materials and methods 
2.1 Materials 
2.1.1 General equipments  
Balances (Sartorius, Göttingen, Germany); centrifuges Hettich Universal 320R and Mikro 
200R (Hettich, Tuttlingen, Germany); laminar flow hood Clean air technique (PMV, 
Utrecht, Netherlands); microscopes Leica DMI 3000B (Leica, Manheim, Germany); Nikon 
E600FN microscope (Nikon Corporation, Tokyo, Japan), multiphoton system LeicaTCS 
SP5 (Manheim, Germany) and Biorad 2100MP (Biorad, Hemel Hempstead, GB); pH-
meter Lab 850 (Schott, Mainz, Germany); spectrometer NanoDrop (Thermo scientific, 
Erlangen, Germany), automated cell counter (Invitrogen), Big ben sphygmomanometer 
(Reister, Germany), MC60 heating stage (Linkam scientific instruments, UK), waterbath 
(Hettich, Tuttlingen, Germany); CO2 incubator (Laborgerate, Heidelberg, Germany) 
 
2.1.2 Consumables 
Disposable scalpel (Feather Safety Razor Co., Osaka, Japan); microscope slides (Thermo 
Scientific, Braunschweig, Germany); microtubes EDTA, with clot activator for sera 
(Sarstedt, Nümbrecht, Germany); glassware (Schott, Mainz, Germany); reaction cups 
1.5ml, 2.0ml (Sarstedt, Nümbrecht, Germany); reaction tubes 15ml, 50ml (Greiner Bio-
one, Frickenhausen, Germany); serological pipettes 5ml, 10ml, 25ml (Laborgerate, 
Heidelberg, Germany); syringes 2ml, 5ml, 10ml, 20ml (Terumo, Leuven, Belgium), 1ml 
(Braun, Melsungen, Germany); flasks, petridishes and petriplates (Greiner Bio-one, 
Frickenhausen, Germany); forceps (Fine Science Tools, Heidelberg, Germany) 
 
2.1.3 Buffers, Chemical Reagents, Dyes 
S-nitroso-N-acetyl-D,L-penicillamine (SNAP) [Sigma Aldrich], acetylcholine [Sigma 
Aldrich], L-NG-nitroarginine methyl ester (L-NAME) [Sigma Aldrich], phorbol 12,13 
dibutyrate ester [Sigma], endothelial cell medium (ECM) [Lonza], Hanks balanced salt 
solution (HBSS) [Lonza], propidium iodide (PI) [Invitrogen], 4',6-diamidino-2-  
 
35 
 
 
                                                                                                             2. Materials and methods  
phenylindole(DAPI) [Invitrogen],  SIN-1 [Invitrogen], DAF-2-DA [Calbiochem], hydrogen 
peroxide [Merck]. 
 
2.2 Animal Care and Mouse strains  
The local ethics committee (FHLM, Maastricht University) on use of laboratory animals 
approved all experiments. Procedures were in accordance with institutional guidelines. 
For ex vivo experiments euthanasia was performed by applying a mixture of CO2 and 
O2, after which arteries were isolated. Carotid artery segments (common part) and 
aorta segments were excised from 20-22 weeks old C57BL6/J (n=6) mice (Charles River, 
Maastricht, the Netherlands). For isolation of PAECs, dutch landrace pigs of 40 to 50 kg 
were euthanized using pentobarbital.  
Table 1: Mouse strains used in the study 
Note: All knockout mouse models were developed by Matijn Poeze and KAP Wijnands; original 
questions are addressable by them. 
 
2.3 Methods 
2.3.1 Spectroscopic measurements  
Spectroscopic measurements were made on a Nanodrop (ND3300, Thermo Scientific) 
fluorescence spectrometer. DAF-2-DA or Cu2FL2E was used for determining spectral 
properties, SNAP was used to release NO in solution. HBSS was used for dissolving DAF-2-
DA or Cu2FL2E to make solutions of suitable concentration. Hydrogen peroxide (H2O2)  
Gene Name Abbreviation Background Description of transgene 
Wildtype None C57BL6 None 
Wildtype None Tie2Cre None 
Arginase-1 Arg-1 C57BL6 Targeted mutation (knock out) 
Nitric Oxide synthase 2 NOS2 C57BL6 Targeted mutation (knock out) 
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was used to determine change in spectral characteristics of DAF-2-DA or Cu2FL2E on 
reacting with this reactive oxygen species. Copper (II)-chloride dihydrate (99%, Sigma 
Aldrich) stock solutions of 1 mM were prepared in Millipore water. Stock solutions of 1 
mM ligands (FL2E) were prepared in DMSO. Probe (Cu2FL2E) concentrations were 
generated by combining stock solutions of CuCl2 and FL2E in a 2:1 ratio. Cu2FL2E or DAF-
2-DA was dissolved in HBSS to get the desired concentration.Cu2FL2E (2 µM) or DAF-2-DA 
(10 µM) was allowed to react with the NO-releasing chemical agent SNAP at pH 7. 
Replicate fluorescence measurements were taken at 1 min for 2 µL of solution of 
Cu2FL2E probe or DAF-2-DA with or without SNAP. For the spectral measurements, a 
white LED (460-650 nm) was used for Cu2FL2E and DAF-2-DA based on the detected 
maximum absorption. 
 
2.3.2 Cytotoxicity assay 
HCAECs were seeded into 24-well plates (500 µL total volume/well, 5000 cells/cm2) in 
complete ECM and incubated at 37oC with 5% CO2 for 72 h until confluent. The medium 
was replaced and cells were incubated with or without Cu2FL2E (2 µM-200 µM) in 
OptiMEM media for 1 h in triplicate. Nine wells were also incubated with DAF-2-DA (10 
µM-200 µM) in triplicate. The medium was removed and replaced with HBSS and 
incubated with double stains; propidium iodide (1.5 µM) for dead/dying cells and DAPI 
(0.1 µM) for nuclear staining. The cells were then incubated for 30 min in the dark. 
Washing and imaging was done in HBSS. The percentages of cell survival values were 
calculated from 5 different images as ratio of PI/DAPI of nuclear staining. 
 
2.3.3 Cell cultures and imaging  
Porcine aortic endothelial cells (PAECs) were isolated from thoracic aorta (112). PAECs, 
human microvascular endothelial cells (HMVECs; Lonza) and human coronary artery 
endothelial cells (HCAECs; Lonza) were cultured in EGM-2MV medium (ECM; Lonza). For 
imaging studies, cells were plated onto poly-d-lysine coated 6 wells plates, and cultured 
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until confluency was reached at 37oC with 5% CO2. To study NO production, the Cu2FL2E 
probe was added in a concentration of 20 µM (40 µM CuCl2 + 20 µM FL2E) in the case of 
PAECs and HMVECs, and 2µM (4µM CuCl2 + 2µM FL2E) in the case of HCAECs, diluted in 
OptiMEM (Invitrogen). Cells were co-incubated with Cu2FL2E and stimulus (10 µM 
acetylcholine [Sigma] (113) or 150 µM H2O2 [Merck]) for 45 min and washed three times 
with HBSS prior to imaging. When stimulated with flow, HMVECs were cultured on Ibidi µ-
slides I-Luer0.4, and cultured for 72 hours in the IBIDI flow system at a rate of 20 
dynes/cm2 shear stress, mimicking the blood flow, and then incubated with Cu2FL2E for 
5min, after which the cells were washed and imaged. For inhibitor studies, HCAECs were 
preincubated with 100 M L-NAME for 1 h prior to addition of Cu2FL2E and stimulus. For 
specificity and sensitivity studies, HCAECs and/or HMVECs were preincubated with 1 µM 
PE and 0.5mM SIN-1 for 5min and 10min respectively prior to addition of Cu2FL2E and 
stimulus. Images were acquired on an inverted fluorescent microscope (Leica 
DMI3000B) equipped with FITC filter and a DFC350 FX camera (Leica). Images were 
taken after removing the DMEM media and washing the cells with Hanks buffered salt 
solution (HBSS). Additionally, two-photon microscopy was performed (see below) in 
some cases. All fluorescent images were corrected for background. 
 
2.3.4 Griess assay  
Cells were seeded in a 6-wells plate and grown until confluent. Medium was removed 
and 1.5 mL of fresh culture medium with or without 150 mM H2O2 was added and 200 L 
was sampled at t = 0, 1, 6, and 24 h. Medium was centrifuged using 10,000 Da MWCO 
polysulfone filters (Sartorius). The supernatant was analyzed using the Total Nitric Oxide 
Assay Kit (Assay Designs). 
 
2.3.5 Tissue preparation 
Segments of murine common carotid arteries (length ~ 6-8 mm) were explanted and 
freed of adipose and connective tissue and carefully handled, only at their outer ends 
without stretching them, to keep them viable. To avoid contact with air, they were kept  
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moist during the whole preparation procedure. Until further processing, arteries were 
stored (maximum 30 min) at 4°C in HBSS, pH 7.4, containing: NaCl 144mM, HEPES 
14.9mM, glucose 5.5mM, KCl 4.7mM, CaCl2 2.5mM, KH2PO4 1.2mM, and MgSO4 1.2mM. 
 
2.3.6 Mounting procedure 
The murine common carotid arteries were explanted and mounted on a perfusion 
chamber (56) filled with 10 mL ECM (37°C). The artery was mounted on two glass 
micropipettes (tip diameters 120-150 µm for carotid arteries) and residual luminal blood 
was carefully removed by gently flushing with HBSS. To correct for the shortening of the 
artery during isolation, a transmural pressure of 100 mmHg was applied (using a 
modified Big Ben sphygmomanometer, Riester, Germany) and the distance between 
the two pipettes was adjusted until the mounted artery was straight. 
After this length adjustment, transmural pressure was set at 80 mmHg to mimic 
physiological conditions. All experiments were performed at 37°C (Linkam scientific 
instruments MC60 heating stage, UK) in the absence of luminal flow. Imaging was 
performed in vessels at a transmural pressure of 80 mmHg and was restricted to the 
central portion of the vessel segment.  
Only weak elastin autofluorescence could be observed with TPLSM. After that the vessel 
was incubated with Cu2FL2E probe (20 µM) for 5 min with luminal flushing of the probe. 
After washing excess probe from the solution and luminal washing, it was again imaged 
with TPLSM. The vessel was then incubated with: acetylcholine (10 µM) or H2O2 (150 µM) 
for 45 min and then washed and imaged and in case of measurements with L-NAME 
(100 µM) it was pre-incubated for 1 h. For precontraction and relaxation of vessels 
experiments, acetylcholine induced signal within 2minutes. For flow experiments, laminar 
flow (2.1Pa) was applied as stimulus for NO production. 
 For endotoxemic arteries studies, L-arginine supplementation was used for NO 
stimulation. Compared to carotid arteries, aorta was more difficult to mount and 
pressurize for our experiments because of its numerous side branches; nonetheless it was 
mastered successfully by ablation of side branches and NO signal was subcellularly 
studied along with vasomotor response.   
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Fig.12 Schematic representation of a vessel perfusion chamber used to mount isolated 
arteries. The distance between the two pipettes is adjustable for correction of the 
arterial length after dissection. Fluid capacity is 10 ml. Inset: mouse carotid artery 
mounted on two glass pipettes with sutures, length-adjusted, and pressurized to 80 
mmHg. 
 
2.3.7 Wire myography 
2mm segments of mouse carotid arteries were mounted between two stainless steel 
wires (40 µm in thickness) connected to a displacement device and an isometric force 
transducer (DSC6; Kistler Morse, Seattle, WA), respectively, in organ chambers (DMT, 
Aarhus, Denmark) filled with KRB solution at 37°C, and they were aerated with 95% O2, 
5% CO2. The segments were progressively stretched to the diameter at which their 
contractile response to 10 µM noradrenaline was maximal. They were relaxed by 
administration of 10 µM acetylcholine. Experiments were repeated after addition of 
Cu2FL2E probe (20 µM) for 5 min in the chamber and washing. 
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2.3.8 In vitro thrombus formation 
Blood drawn from human volunteers was stored in vacutainer tubes with anticoagulant 
(trisodium citrate). 0.5ml of blood was used for thrombus formation (care was taken to 
form small thrombus, in order to save labeling expense). On addition of 7.5µl of Cacl2 
(1M) to 0.5ml blood for 90min at 37 degrees C, a thrombus is formed. Labeling of the 
thrombus with cDot-peptide-TAMRA conjugate and unconjugated cDots was done for 
90min at 37 degrees C, with occasional shaking of the tubes to ensure non-sticking of 
thrombus on the wall of the tube and uniform staining of the thrombus. Followed by 
extensive washing with PBS, thrombi were dipped in PBS buffer for imaging. 
 
2.3.9 Two-photon imaging 
The perfusion chamber with artery or a 6-well plate with cultured endothelial cells was 
positioned on a Leica ultrafast TCS SP5 multiphoton microscope. The microscope was 
integrated with a DM6000 CFS (Confocal fixed stage) system, a DFC360FX camera 
system and an AOBS (Acousto optical beam splitter) [Leica, Manheim, Germany] was  
used. The excitation source was a Chameleon Ultra Ti: Sapphire laser (690-1040 nm) 
(Coherent Inc. Santa Clara, CA, USA), tuned and mode-locked at 800 nm and 
producing light pulses of repetition rate 80 MHz with duration < 200 femtosecond. The 
pulses reached the sample through the Leica HCX APO L 20x/ 1.0W microscope 
objective (20 X, water dipping, numerical aperture 1.0, working distance 2 mm, access 
angle 39 degrees), connected to an upright Leica DM6000 CFS microscope. An optical 
zoom in the scan head achieved further magnification. Super Z-galvo was used for fast 
and accurate XYZ and XZY scan mode. External detectors were used for collecting 
emitted lights from the sample. When desirable the fluorescence was detected by one 
independent photomultiplier tube (PMT) for the green wavelength region (508-523 nm) 
and another independent photomultiplier tube (PMT) for the blue wavelength region 
(400-410 nm; for collagen and 450-480nm; for Syto 41). Images of 512 × 512 pixels were 
obtained. For quantification purposes, the intensities in the green channel were used. 
The excitation wavelength of 800 nm was chosen since we found  
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that at this wavelength both traps and adducts were effectively excited. No additional 
image processing was performed. For imaging of the endothelial cells and carotid 
arteries, an imaging speed of 50 Hz was used to improve signal-to-noise ratio. To prevent 
photochemical and thermal damage to the arteries, laser power was kept as low as 
possible(56).                                                                                                                                                                                       
Images were recorded in the XY-plane. Fluorescence images were taken after 
removing the EGV-2M media and by washing the cells or flushing the artery with Hanks 
buffered salt solution (HBSS). Inaccurate alignment of the pipettes in the perfusion 
chamber usually caused imaging of the artery in a slightly oblique plane. Series of XY-
images at successive depths (Z-stack) were collected for reconstruction of 3D images. 
Luminal diameters were obtained from XZ or YZ-images. To obtain XZ- or YZ-images with 
square pixels, z-step distance was equal to the pixel dimensions in XY-direction. In case 
of vessels, the scanning takes place in the direction from adventitial layer to the intimal 
layer, making optical sections and compiling in Z-stacks. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.13 Two-photon microscopic setup (Leica TCS SP5) 
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For quantification of fluorescence intensity from the images, various regions of interests 
(ROIs) were selected and processed using LASAF-Lite (Leica Systems) software to 
calculate the fluorescence intensity (au) per ROI. Average measure of fluorescence 
intensities were taken for quantitative assessment, in every group of vessels. 
 
2.3.10 Two-photon ex vivo NO-production measurements in carotid arteries of 
endotoxemia mouse model 
To determine the endothelial NO production during endotoxemia, carotid arteries of 
control (n=6) and Argfl/fl/Tie2-Cretg/- mice (n=6) treated with LPS were measured. To 
specify the origin of the NO production in the Argfl/fl/Tie2-Cretg/- endothelial cells (NOS3 
or NOS2), the NO production in carotid arteries with pharmacological inhibition (1400W; 
n=5) or genetic ablation of NOS2 (n=3) were additionally measured.  
The 2-photon NO measurements and microscopic setup used for imaging has been 
described previously. In brief, carotid arteries were excised and mounted and 
pressurized in a perfusion chamber (IDEE BV, Maastricht, The Netherlands). Vessels were 
pre-loaded with the fluorescent copper-based NO probe for 5 minutes after which 
basal and arginine stimulated fluorescent measurements were performed using a Leica 
ultrafast TCS SP5 multiphoton microscope integrated with DM6000 CF system, DFC360FX 
camera system and AOBS (Leica, Manheim, Germany). Images were analyzed using 
LASAF acquisition software (Leica, Manheim Germany) 
 
2.4 Image analysis 
Images were analyzed using LASAF acquisition software (Leica, Manheim Germany). 3D 
reconstructions of images were made using Image-Pro Plus 6.3 software (Media 
Cybernetics Inc., USA). NO mediated vasomotor responses, i.e. functionality of arteries, 
in XZ- or YZ-scans of the vessel. Signal quantification was done by using LASAF software 
were determined in three carotid arteries and measured as changes in luminal diameter 
to check florescence intensity (au) in different regions of interest. 
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Fig.14 (a) Image analysis: Step1; selection of region of interests (ROI), setting right 
channel to quantify for relative fluorescence in each of ROI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.14 (b) Image analysis: Step2; checking individual profile for relative fluorescence; 
setting each ROI to obtain profile. 
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Fig.14(c) Image analysis: Step3; obtaining statistics (mean value) of relative 
fluorescence from each ROI. 
 
2.5 Statistical analysis 
Results were presented as mean ± standard deviation and were tested for significance 
using the t-test (non-parametric test for two independent groups). A value of P < 0.05 
was considered to be statistically significant. Linear regression analysis was performed to 
assess best fit relation, slope and correlation coefficient. R square value near to 1.0 
shows best-fit predictability. All statistical analyses were performed using Graph Pad 
Prism software (GraphPad Software Inc. USA). 
Statistical analysis of the endotoxemia data was performed using SPSS 15.0 (SPSS, 
Chicago, IL). One-way analysis of variance (ANOVA) was performed with post-hoc 
Bonferroni correction between groups to determine significant differences. Data are 
represented as mean and standard error of the mean (SEM). P–values below 0.05 were 
considered as statistically significant.  
 
45 
 
 
3. Results 
3.1. Validation of the NO probe for vascular biology 
3.1.1. Cu2FL2E is more sensitive and specific than DAF-2-DA for NO detection  
To underscore the sensitivity of Cu2FL2E to NO, its behaviour was tested using various 
concentrations of SNAP as NO donor 17 and compared with that of the conventionally 
used DAF-2-DA. At a concentration of 100 µM in PBS at pH=7.4 and 37°C, SNAP 
produces 1.4 µM NO per min (114, 115). For Cu2FL2E (2 µM) the lowest detectable 
concentration of SNAP after 1min was found to be 2.5 µM, corresponding to ~35nM NO, 
while for DAF-2-DA (10 µM) the lowest detectable concentration of SNAP was 5 µM, 
corresponding with an NO concentration of 70nM (Fig.15a). Subsequently, the 
concentration dependence of Cu2FL2E and DAF-2-DA to SNAP was linearly fitted. The 
concentration dependence (Fig.15b) of Cu2FL2E exhibited a higher correlation 
coefficient (R square = 0.9491 for Cu2FL2E, R square = 0.6814 for DAF-2-DA), and higher 
steepness for Cu2FL2E (Slope = 0.08824 ± 0.003864) while for DAF-2-DA (Slope = 0.02151 ± 
0.002780) indicating best fit values for Cu2FL2E. 
a                                                                             b 
 
 
 
 
 
 
 
 
 
Fig. 15 NO sensitivity of Cu2FL2E compared with DAF-2-DA; (a) Fluorescence response of 
DAF-2-DA and Cu2FL2E (both 2 µM) to various concentrations of NO after 1 min of SNAP 
administration. n = 5, (b) Linear regression curve plotted from (a). 
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Finally, the specificity and reaction speed of Cu2FL2E for NO was compared with that of 
DAF-2-DA using 50 µM of SNAP. Additionally, although the specificity of Cu2FL2E for NO 
over H2O2, HNO, NO2-, NO3- and ONOO- has already been shown before (46, 47), we 
compared the reaction of both probes to SNAP with that to H2O2, (150 µM), as the latter  
                                                  a 
 
 
 
 
 
                                                                                                                                                                                                          
 
 
                  b                                                                        c       
 
 
 
 
 
 
 
 
 
Fig. 16 Specificity of Cu2FL2E compared with DAF-2-DA for NO and H2O2 ; Fluorescence 
response of (a) Cu2FL2E compared with DAF-2-DA after 1 min and after 15 min, (b) DAF-
2-DA (2 µM) response after 15 min, (c) DAF-2-DA (10 µM) response after 15 min 50 µM 
SNAP in PBS at 37oC, pH 7.4 was used to administer NO. The spectra were obtained 1 
min /15min after SNAP addition. [H2O2] = 150 µM, [Cu2FL2E] = 2 µM, [DAF-2-DA] = 2 µM / 
10 µM, n = 5. Error bars indicate s.d.  
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is used in our study as one of the stimuli for NO production in cells and vessels (116, 117, 
118). Fig.16a shows that 1min after SNAP addition Cu2FL2E (2 µM) reacts with NO, 
resulting in a 5-fold increase in fluorescence intensity compared to background. 
Addition of H2O2 generated a smaller (2-fold) increase in fluorescence intensity. These 
data correspond with data of McQuade L.E. et al (47).  
In contrast, the fluorescence of DAF-2-DA (10 µM) after 1min increased only slightly in 
response to SNAP, and was 4-fold less than that of Cu2FL2E. Addition of H2O2 to DAF-2-
DA, however, resulted in a robust (5-fold increase in fluorescence) response. Upon 
increasing the incubation time of SNAP to 15min, DAF-2-DA (10 µM) showed a 3-fold 
increase in fluorescence, but the same increase was also apparent for H2O2 (Fig. 16b). 
Lower concentrations of DAF-2-DA (2 µM) failed to show any response under similar 
conditions or even after longer time periods (Fig. 16c). These findings underscores the 
superior NO detection characteristics of Cu2FL2E over DAF-2-DA. 
To study the cytotoxicity of the two probes, we loaded human coronary endothelial 
cells (HCAECs) with either Cu2FL2E or DAF-2-DA. Toxicity at 2 µM Cu2FL2E, the regular 
concentration for cellular imaging of NO, was undetectable (Fig.17) and the upper limit 
for toxicity was 20 µM. In contrast, the standard 10µM concentration of DAF-2-DA 
resulted in extensive cell death (< 10% viability). This excludes DAF-2-DA for further vital 
cell and vascular studies.  
 
 
 
 
 
 
 
 
 
 Fig. 17 Cytotoxicity assay; with different concentrations Cu2FL2E and DAF-2-DA using 
ratio of PI/DAPI of nuclear staining (n=5). 
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3.2 Visualization-analysis of NO metabolism in vitro in endothelial 
cells  
3.2.1 NO production can be imaged specifically in vitro in endothelial cells with 
Cu2FL2E 
 The ability of Cu2FL2E to detect NO produced in different EC types under the influence 
of various stimuli was investigated. Cu2FL2E-loaded porcine aortic endothelial cells 
(PAECs) were stimulated with H2O2 and time-dependent fluorescence enhancement 
was monitored. From literature reports (119), it is known that H2O2-induced NO synthesis 
in ECs is a rather slow event. Indeed, H2O2 activates eNOS, and therefore NO 
production, through coordinated phosphorylation and dephosphorylation of eNOS 
amino acid residues between 15 to 45min after H2O2 supplementation. The activation is 
reported to last for 15min. Therefore, we followed NO production over 90 minutes after 
H2O2 supplementation (150 µM). In agreement with the above, we detected NO 
production as seen from a rise in fluorescence intensity above background in ECs, 
starting 5min after H2O2 exposure. After 45min the fluorescence intensity exhibited a 
plateau (Fig. 18a&b). Indeed, due to its chemistry, the NO-bound probe remains 
fluorescent (46, 47) and therefore over time the signal intensity increases. The result is a 
slow accumulation of fluorescence. Eventually, a signal plateau is reached when NO 
synthesis is reduced over time. To further address the specificity and sensitivity of the 
probe, we measured the NO response to H2O2-stimulated HCAECs with and without 
addition of SIN-1, a well-known eNOS-uncoupler (120) to specifically block eNOS 
activity. This resulted in abrogation of fluorescence signal in the presence of SIN-1 
(shown later), reflecting potent uncoupling of eNOS. In presence of L-NG-nitroarginine 
methyl ester (L-NAME) is a widely used non-specific nitric oxide synthesis inhibitor (77, 
114, 116 117, 119),  the fluorescence signal after various stimuli (H2O2 and Ach) was 
significantly weaker (2 to 3-fold, p-value < 0.0001) than in the absence of the inhibitor, 
indicating less NO production in HCAECs (Fig. 18c&d). NO detection with Cu2FL2E was 
considerably faster (starting after 5 min) than the traditional Griess assay (121), which 
require hours of stimulation for significant detection. (Fig. 19) 
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Fig.18 Detection of NO with Cu2FL2E produced by endothelial cells in vitro. (a) NO 
detection in porcine aortic endothelial cells (PAECs); Left: 45 min incubation of Cu2FL2E 
(20 µM). Right: 45 min incubation of Cu2FL2E (20 µM) and H2O2 (150 µM). Top: bright-field 
images of cells. Bottom: fluorescence images of cells. Scale bars, 50 µm. (b) 
Quantification of fluorescence intensity plotted against incubation time. (c) Detection 
of NO with Cu2FL2E in HCAECs cells, with or without NO-inhibitor (L-NAME). Shown are 
the fluorescence images after 45min co-incubation of the probe (Cu2FL2E =2 µM) with 
H2O2 (150 µM), L-NAME (100 µM), and/or ACh (10 µM) according to scheme. Scale bars, 
75 µm. (d) Quantification of fluorescence intensity from (c) plotted against each 
condition mentioned in (c) (n = 5) 
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                  Fig. 19 Griess assay; for nitrate determination 
 
In line with our experience we have been using low-mid passage HCAECs (passage <6), 
for our cellular studies. These data again pinpoint the NO specific response of the probe.  
To demonstrate the efficacy of ACh stimulation on cellular signaling in HCAEC cells, we 
checked for colocalization of eNOS phosphorylation and NO production. Results show 
correlation of phosphorylated eNOS with the measured NO signal (Fig. 20), which again 
pinpoints at the non-toxic nature of the probe, since the probe does not interfere with 
cellular metabolic activity. 
 In order to address the specificity and sensitivity of the probe in a vascular setting, we 
challenged HCAECs with phorbolester (PE). We observed an increase in NO production 
(high fluorescence intensity) when ECs were stimulated with phorbolester (which 
activates NADPH oxidase). There was no significant additive effect of ACh or H2O2 
stimulation (Fig. 21). NADPH oxidase is a major source of intracellular ROS production 
and could decrease NO availability by uncoupling eNOS. A decreased NO signal in ECs 
was therefore anticipated (activated by PE). 
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Fig.  20  HCAECs with eNOS phosphorylation; showing clear staining of phospho-eNOS 
(in red) with nuclear stain (DAPI, in blue) and NO signal (in green). This indicates the low-
mid passage HCAECs (passage <6) have the ability to respond to ACh-induced NO 
synthesis. 
Instead, we saw an increased NO signal, which can be explained by the observation 
(122) that ROS via NADPH oxidase activation can also enhance eNOS activity and 
subsequently enhances localized NO production. This effect was mechanistically 
attributed by ROS enhanced association of hsp90 with eNOS, thereby facilitating rather 
than inhibiting NO synthesis. In line with the positive effect of PE in our hands we consider 
a comparable mechanism to act in the increased NO signal detected with the Cu2FL2E 
probe.    
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Fig. 21 NO detection in human coronary arterial endothelial cells (HCAECs) with PE; 
fluorescence intensities obtained with co-treatment of Cu2FL2E (20 µM) and PE (1 µM), 
showing increase in fluorescence intensity when stimulated with PE due to ROS 
enhanced association of hsp90 with eNOS, thereby facilitating NO synthesis. No 
significant additive effect of ACh or H2O2 stimulation was observed. 
 
Furthermore, we evaluated the ability of Cu2FL2E to detect a more vascular and 
physiological stimulus, namely flow-induced (116, 117, 123) endogenous NO production 
in human microvascular endothelial cells (HMVECs). ECs subjected to flow adapt their 
NO production by activation of eNOS. After 72hrs of flow, cells will have increased their 
eNOS activity. In our setup, the probe is added to ECs (after 72hrs of flow) and the 
fluorescence intensity of the cells is monitored at 5min (the minimum time needed to 
establish the imaging), imaging carried out under flow. A rapid, 4-fold fluorescence 
increase was detected in cells that were cultured under flow (2.1Pa, 72 hrs) whereas  
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cells cultured under static (no flow) conditions remained negative (p-value = 0.0034) 
(Fig. 22a&b). This underscores the immediate reaction of the probe to increased NO 
production.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22 Detection of NO with Cu2FL2E produced by endothelial cells in vitro with flow. 
(a)Left: NO detection in HMVECs in static condition (i.e. without flow) with Cu2FL2E (20 
µM). Right: under flow condition (flow rate= 2.1 Pa, time=72 h) with Cu2FL2E (20 µM). 
Scale bars, 50 µm. (b) Quantification of fluorescence intensity from (a), (c) NO detection 
in HMVECs in flow condition (flow rate= 2.1Pa, time=72 h) with Cu2FL2E (20 µM) and 
without / with SIN-1 (0.5 mM). Scale bars, 50 µm, (d) Quantification of fluorescence 
intensity from (c). Error bars indicate s.d. 
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When the cells under flow were concomitantly incubated with SIN-1, there was 
abrogation of fluorescence signal (p-value = 0.0005) (Fig. 22c&d), showing potent 
uncoupling of eNOS. These data again proves the NO specific response of the probe 
and its validity to study cellular NO synthesis.  
 
3.3 Visualization of NO synthesis and vasomotor responses in the 
vasculature 
3.3.1 NO production can be imaged and visualised ex vivo in non-precontracted 
murine carotid arteries and aortas with Cu2FL2E 
Murine carotid arteries were explanted and mounted in a custom-made perfusion 
chamber (56, 80). Weak autofluorescence was detected from elastin fibres of the 
vessel, presenting clearly distinguishable background fluorescence (Fig. 23a&b). This 
autofluorescence was independent of the presence of probe and can be used to 
locate relevant vascular layers. Individual SMCs and ECs could not be identified at the 
starting point of analysis (i.e. in absence of the probe or in the presence of the probe 
but without external stimulus) due to lack of sufficient cellular autofluorescence or basal 
NO signal above threshold of detection, respectively. When subsequently the vessel was 
incubated with ACh or H2O2 for 45 min, and subsequently washed, the fluorescence 
signal clearly reflected the presence of NO in ECs of the intimal layer and, to a lesser 
extent, in SMCs of the medial layer (Fig. 23c-f). Next, quantification of NO signal in 
vascular cells showed that after stimulation (here with H2O2), fluorescence increased 
more significantly over background levels in ECs (p value = 0.0091) than in SMCs (p 
value = 0.0481) (Fig. 23g). 
Additionally, flow-mediated (2.1 Pa) stimulation of NO production in vessels after 45min 
of flow, could be seen in ECs. In this case, the increase in fluorescence over background 
levels for ECs was significant (p value = 0.0311), whereas the fluorescence change in 
SMCs was not significant (p value = 0.4664) (Fig.23h). Comparable results were obtained 
after ACh stimulation (Fig. 24). Proper labelling and focusing on the cells in different 
planes is demonstrated by nuclear staining (DAPI) in the merged images (Fig. 25). 
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Fig. 23 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E. (a) & (b) Magnified images of vessel showing basal NO signal detected after 5 
min incubation of Cu2FL2E (20 µM) without any stimulus at medial and intimal focal 
planes, respectively. (c) NO signal detected in smooth muscle cells (SMCs) and (d) 
endothelial cells (ECs) of the tissue with 5 min incubation of Cu2FL2E (20 µM) and, 
subsequently 45min incubation of H2O2 (150 µM). Scale bars, 50 µm, (e) & (f) Magnified 
images of vessel showing NO signal detected after 5 min incubation of Cu2FL2E (20 µM) 
and subsequently, 45 min incubation of H2O2 (150 µM) in SMCs at medial plane and in 
ECs at intimal plane respectively, (g) Quantification of spatial distribution of 
fluorescence intensity as measure of NO in cells of vessel wall stimulated with H2O2. (n = 
5). (h) Quantification of spatial distribution of fluorescence intensity as measure of NO in 
cells of vessel wall stimulated with flow (flow rate= 2.1 Pa, time=45min), (n = 5). 
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Fig. 24 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E with ACh. (a) & (b) Autofluorescence in SMCs & ECs of the tissue respectively, 
without Cu2FL2E & ACh, (c) & (d) Basal NO signal detected after 5 min incubation of 
Cu2FL2E (20 µM) without any stimulus in SMCs & ECs, respectively. (e) & (f) NO signal 
detected in SMCs & ECs of the tissue respectively, with 5 min incubation of Cu2FL2E (20 
µM) and 45min incubation of ACh (10 µM). Scale bars, 50 µm.  
 
Compared to the carotid artery, the aorta was more difficult to mount and pressurize 
because of its numerous side branches; nonetheless proper mounting was mastered 
successfully by careful ablation of side branches.   
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Fluorescence signal visualization in aortic endothelial cells was possible ex vivo, resulting 
in NO-mediated structural- functional imaging. This demonstrates limited capability of 
SMCs to directly respond to this physiological trigger. ECs were observed 45 minutes 
after probe addition and subsequent ACh stimulation (p value = 0.0462).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25 DAPI staining of SMCs and ECs; Magnified images of vessel showing NO signal 
detected in smooth muscle cells (SMCs) and endothelial cells (ECs) of the tissue with 5 
min incubation of Cu2FL2E (20 µM) and, subsequently 45 min incubation of H2O2 (150 
µM), in medial and intimal focal planes respectively. The cells are also stained with 
nuclear stain (DAPI) and merged images can be seen. 
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In contrast to our findings in the carotid artery (stimulated with ACh) there was no 
apparent and significant NO production in SMCs, perhaps due to lower amount of NO 
generated in aorta (Fig. 26). However, 3D analysis and reconstruction of the aorta shows 
NO-mediated relaxation occurs with an increase in luminal diameter. 
 
      a                                                                                  b 
 
 
 
 
 
 
 
 
 
 
Fig. 26 Detection of NO produced in explanted murine aorta ex vivo using Cu2FL2E in 
aorta: (a)Quantification of spatial distribution of fluorescence intensity as measure of NO 
in cells of vessel wall stimulated with flow (n = 5), (b) Functional imaging of NO; 3D 
reconstruction of vessels with Cu2FL2E without/ with stimulus (here Ach) showing luminal 
diameter measured from arteries. 
 
3.3.2 Time-profile of changes in fluorescence intensity in ECs and SMCs of non-
precontracted carotid arteries after stimulation 
Diffusion profile for NO in the vascular cells was obtained to investigate the duration of 
NO production and storage in these cells (Fig. 27), with monitoring at regular time points. 
Here, the cells were stimulated with H2O2. A similar profile was obtained with ACh 
stimulations (data not shown). By obtaining diffusion profile, we specifically addressed 
compartments and temporal profiles of NO production in the vasculature. Indeed, due  
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to its chemistry the probe remains fluorescent and thereby with time, signal intensity 
increases in SMCs due to this slow accumulation of NO passing from ECs. The decrease 
in NO signal in ECs most probably is the result of high NO-probe complex saturation and 
subsequent bleaching.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27 Profiles of NO occupancy in SMCs and ECs in carotid artery, when stimulated with 
H2O2. (n = 5). With time, signal intensity increases in SMCs due to slow accumulation of 
NO passing from ECs. The decrease in NO signal in ECs at longer time point is probably 
the result of NO-probe complex saturation and subsequent bleaching.  
 
3.3.3 NO production can be imaged and visualized ex vivo in precontracted 
murine carotid arteries with Cu2FL2E 
In most physiological experiments, ACh is added after precontraction of the vessel. To 
visualize the NO production of carotid arteries after precontraction, we first applied 
Noradrenaline (NA) as a vasoconstrictor, after which the time curve of ACh-induced 
fluorescence response from NO signal was monitored in ECs and SMCs. In contrast to 
the results obtained in carotids without precontraction, where only a slow increase in 
NO signal was observed after ACh stimulation, here already after 2.5 min (the first  
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possible measurement point) a detectable fluorescence change (Fig. 28a, b &c) was 
seen in ECs. In SMCs no significant increase in fluorescence was seen. The fluorescence 
in ECs continued to increase during 15min after ACh stimulation (Fig. 28d). 
 
 
Fig. 28 Detection of NO produced in explanted murine carotid arteries ex vivo using 
Cu2FL2E with precontraction. (a) Detection of NO in response to NA (ECs and SMCs are 
not apparent), (b) Detection of NO in post NA and ACh stimulation (2.5min) (ECs and 
SMCs are apparent), (c) Syto 41 staining of nucleus of ECs and SMCs, (d) plot of 
fluorescence intensities of the ECs and SMCs (from carotid artery) measured with NA 
and ACh stimulation for 15min, (e) luminal diameter measured from arteries with 
conditions mentioned in a & b, error bars indicate s.d. (n=3) 
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3.3.4 Cu2FL2E does not influence the contractile behaviour of carotid arteries 
after pre-contraction  
In order to demonstrate the non-toxicity of Cu2FL2E and to show the absence of an 
influence of Cu2FL2E on contractile behavior of the carotid arteries, studies on arteries in 
the myograph were performed. In this experimental setup, the excised murine carotid 
artery was stretched in the myograph chamber and was challenged with noradrenaline 
(NA) (10 µM) for precontraction. 
Fig. 29  Original trace recordings of percentage of relaxation of mouse carotid arteries in 
a vessel myograph. Segments of the carotid artery (2 mm long) from wild-type mouse 
and were mounted in a vessel myograph and vessel pretension was adjusted in steps to 
resemble an intraluminal pressure of 100 mm Hg. Vessels were first contracted with 
indomethacin, washed, and then contracted by 10µM noradrenaline. Acetylcholine 
(10µM) was then added in the vessel bath. ACh induced relaxation of the vessel. The 
same procedure was repeated, this time first with incubation of the vessel with Cu2FL2E 
(20µM) for 5min, then NA and Ach were added. Ach induced relaxation was not 
influenced by Cu2FL2E as could be seen from the percentage of relaxation. 
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Vasomotor response to ACh (10 µM) was then checked as positive control. 
Subsequently, the same experiment was performed several times in the presence of 
Cu2FL2E (20 µM).  The result (Fig.29) revealed no change in the percentage of relaxation 
and time course of the dilation in the presence of Cu2FL2E. Hence, this demonstrates the 
non-toxic nature of the probe and its utility in functional assessments. 
 
3.3.5 3D reconstruction of the vessel 
As shown before, in a non-stimulated control artery elastin layers are visible, while ECs 
and SMCs are not visible. On stimulation, SMCs and ECs become visible due to the NO-
induced rise in fluorescence intensity. Series of XY-images at successive depths (Z-stack, 
step size 0.99µm) were collected for reconstruction of 3D images (Fig. 30). 2D and the 
3D reconstructions expose the medial and intimal layer of the vessel wall. Thus, from 
every obtained optical section, a detailed study of delicate structures in the vessel wall 
was possible. 
 Fig.30 3D reconstruction of vessel; (a) 3D reconstruction of a section of the vessel 
showing “spindle shaped” smooth muscle cell and endothelial cell (several indicated by 
red circles) alignment with respect to the direction of flow, (b) 3D reconstruction of the 
intimal side of the vessel exposing smooth muscle cells and endothelial cells at the 
media-intima interface to assess the structure of the cells in relation to variable NO 
release, (c) 3D reconstruction of the adventitial side of the vessel showing thin elastin 
fibres and fibroblasts at the adventitia-media interface. 
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The NO signal was apparent in SMCs and ECs at the medial-intimal interface of the 
vessel wall as could be seen with good spatial resolution. Furthermore, these 3D optical 
sections could be used for functional analysis, such as determining the luminal diameter. 
Unfortunately, this way of determining luminal diameters is rather slow, since 3D stacks 
have to be imaged. Furthermore, to carry out 3D stacking, the vessel diameter first 
needs to be stabilized. These two factors exclude “on the fly” diameter calculations 
during the intensity experiments. 
 
3.3.6 NO-mediated vasomotor response of arteries can be determined at end 
point and correlated with the change in fluorescence intensity 
Since changes in vascular diameter cannot be measured during the intensity 
experiments, vascular diameters of explanted carotid arteries were assessed before and 
after the dynamic intensity experiments. To that end, luminal diameters were obtained 
from XZ images after 3D reconstruction. On stimulation of non-precontracted carotids 
by ACh for 45 min, the luminal diameter of the ACh-stimulated arteries increased 
significantly when compared with non-stimulated arteries (p value = 0.0451) (Fig. 
31a&b). Also the fluorescence intensity of the ACh-stimulated arteries increased 
significantly when compared with non-stimulated arteries (p value = 0.0427) (Fig. 31c).In 
contrast, when NO synthesis in the vessel was blocked by L-NAME, luminal diameter of 
arteries decreased significantly, (Fig. 31d&e) even after administration of ACh (p value = 
0.0168) and also the fluorescence intensity decreased (p value = 0.046) (Fig. 31f). 
Functionality of the ECs and SMCs of mounted carotid arteries was also evaluated by 
testing the acute vasomotor responses (change in luminal diameter) to the vasodilator 
acetylcholine (10 µM) during (10 µM) NA- induced vasoconstriction. Both were 
administered extraluminally. The average luminal diameter of the arteries decreased 
(from 200±10 µm to 150±20 µm) upon administration of NA, and when ACh was added 
the average luminal diameter of the arteries increased (from 150±20 µm to 180±20 µm). 
These results not only establishes the viability of the mounted vessels, but also 
demonstrate that Cu2FL2E does not crucially affect the enzymatic activity of NO 
synthesis, NO bioavailability or of downstream pathways involved in SMC-relaxation. This  
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also establishes the importance of this method in the forefront of simultaneous structural-
functional imaging of NO in the vasculature. We also evaluated the influence of 
removal of the NO donor SNAP (Fig. 32a) on the stability of the probe and the influence 
of copper ions on the sensitivity of the probe (Fig. 32b). Both showed no effects on the 
integrity of the probe. 
 
 
Fig. 31 Functional imaging of NO; (a) 3D reconstruction of vessels with Cu2FL2E without/ 
with stimulus (here ACh), (b) luminal diameter measured from arteries with conditions 
mentioned in (a), (c) normalized fluorescence intensities of the arteries with conditions 
mentioned in (a), (d) 3D reconstruction of vessels with Cu2FL2E without/ with stimulus 
(here ACh) and also in combination with L-NAME, (e) luminal diameter measured from 
arteries with conditions mentioned in (d), (f) normalized fluorescence intensities of the 
arteries with conditions mentioned in (c), error bars indicate s.d. (n=5) 
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Fig. 32 Effect of SNAP and CuCl2 on integrity of Cu2Fl2E (a) Fluorescence response of 
HCAECs with Cu2Fl2E to SNAP, (b) Fluorescence response of DAF-2-DA to SNAP in 
presence of CuCl2.,  n = 5 (accumulations in both the cases). Error bars indicate s.d.  
 
3.4. Visualization of NO synthesis and vasomotor response in the 
carotid artery in wild type and Arginase-1 deficient mice 
NO imaging in a model of cardiovascular complication, where NO is a major regulator, 
is indispensable. Therefore, we applied our Cu2FL2E –TPLSM approach to unravel the role 
of NO under vascular pathologic conditions. This methodology helped in determining 
the spatiotemporal relationship between vascular anatomy and NO production with 
relative quantification of NO and exploration of NO-mediated vasomotor response. 
 
3.4.1 NO synthesis in normal and endotoxemic carotid artery of wild type mice: 
effect of arginine supplementation 
In this study, a newly developed prolonged murine endotoxemia model (18 hours) (123) 
(shown on page 31) was used to visualize modulated NO production and also to 
investigate the effect of arginine supplementation during ongoing endotoxemia. 
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.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33  Detection and quantification of NO produced in healthy explanted murine 
carotid arteries ex vivo with and without arg supplementation; NO signal detected in 
smooth muscle cells (SMCs) and endothelial cells (ECs) of the tissue with 5 min 
incubation of Cu2FL2E (20 µM) and, subsequently 30min incubation of L-ARG (67 µM). 
Scale bars, 50 µm.  
 
This murine model of prolonged endotoxemia mimics the human situation where the 
arginine-NO metabolism is disturbed due to prolonged exposure to endotoxin. 
Consequently, in this condition, arginine availability is reduced along with associated 
decreased NO production. Cu2FL2E –TPLSM imaging modality was used as the tool to 
establish if extracellular arginine supplementation can restore NO production at sub-
cellular level during endotoxemic condition. The results demonstrate that L-arginine 
supplementation under normal condition, does not improve the localized NO 
production in ECs (as no significant increase in fluorescence intensity can be seen),  
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while in SMCs increased fluorescence intensity on addition of arginine (Fig. 33) can be 
observed. This observation can be explained, as it is known that extracellular arginine 
forms only arginine pool for iNOS induced NO production. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34  Detection and quantification of NO produced in endotoxemic explanted murine 
carotid arteries ex vivo with and without arg supplementation; NO signal detected in 
smooth muscle cells (SMCs) and endothelial cells (ECs) of the tissue with 5 min 
incubation of Cu2FL2E (20 µM) and, subsequently 30min incubation of L-ARG (67 µM). 
Scale bars, 50 µm.  
 
In contradiction, during ongoing endotoxemia, L-arginine supplementation improved 
the localized NO production in both ECs (as seen by a significant increase in 
fluorescence intensity) and SMCs. The later could be due to either iNOS induced NO 
production in SMCs or the increased amount of NO diffused from ECs (Fig. 34). The 
participation of various NOS in context to this was not studied. Also the effect of  
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extracellular arginine supplementation on microcirculation balance was not studied. 
However, the vasomotor response of the explanted carotid arteries (functionality) was 
assessed by simultaneous measurement of NO-related Cu2FL2E fluorescence and NO 
mediated vasomotor response (i.e. the change in luminal diameter). Luminal diameters 
were obtained from XZ images after 3D reconstruction. L-arginine supplementation (for 
30 min), increased fluorescence intensity for both SMCs and ECs in endotoxemic arteries 
compared to normal arteries. The average luminal diameter of the endotoxemic 
arteries also increased (from; 100±10 µm, to; 170±10 µm) upon administration of arginine 
compared with normal arteries (from; 200±10 µm, to; 200±20 µm) (Fig. 35). Conclusively, 
Cu2FL2E-TPLSM can be considered to be an important tool for the visulaization of 
modulated NO production in disease condition, and hence this approach could 
contribute to basic scientific research hugely, where NO is an important biomarker for 
cardiovascular complication. One can benefit from early diagnosis of modulated NO 
production in these vascular diseases. 
 
 
 
 
 
 
 
 
 
 
Fig. 35  Functional imaging of NO in endotoxemic arteries; 3D reconstruction of vessels 
with Cu2FL2E without/ with L-ARG. 
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3.4.2 NO synthesis in normal and endotoxemic carotid artery of Arginase-1 
knockout mouse (Argfl/fl/Tie2-Cretg/-): effect of arginine supplementation 
Endothelial cells of the tissue specific Argfl/fl/Tie2-Cretg/- mice (Argfl/fl/Tie2-Cretg/- + LPS) 
exhibited more ex vivo NO production compared to the endothelial cells of the control 
mice (Control + LPS) (Fig. 36), however the origin (NOS2; iNOS or NOS3; eNOS) of the 
enhanced NO production needed to be unraveled.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  36  Ex vivo NO production measured in carotid arteries of LPS-treated Control and 
Argfl/fl/Tie2-Cretg/- mice. The endothelial cells in carotid arteries of Argfl/fl/Tie2-Cretg/- mice 
exhibited significantly more ex vivo NO production compared to endothelial cells of 
Control and NOS2-/- mice. In vivo treatment with 1400W and in Argfl/fl/Tie2-Cretg/- mice 
showed less ex vivo NO production compared to the Argfl/fl/Tie2-Cretg/- (LPS-treated) 
group. NO production displayed as normalized fluorescence intensity (au). 
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To test whether, the effects of arginase I depletion were dependent on the increased 
NOS2-mediated NO production, a selective NOS2 (iNOS) blocker, 1400W was 
administered. In vivo supplementation of 1400W in the Argfl/fl/Tie2-Cretg/-+ LPS group, 
resulted in significant lower ex vivo NO production in the endothelial cells of these 
animals, measured with two-photon microscopy (Fig. 36) and Cu2FL2E. The NO-
production observed in endothelial cells of the Argfl/fl/Tie2-Cretg/- + LPS+1400W carotid 
arteries was not significantly different from the concentrations observed in the 
endothelial cells of the Control+LPS carotid arteries.  
 
 
 
 
 
 
 
t 
 
 
 
 
 
 
Fig. 37  Detection and quantification of NO produced in explanted murine arg -/- carotid 
arteries ex vivo using Cu2FL2E; NO signal detected in smooth muscle cells (SMCs) and 
endothelial cells (ECs) of the tissue with 5 min incubation of Cu2FL2E (20 µM) and, 
subsequently 30min incubation of L-ARG (67 µM). Scale bars, 50 µm.  
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In contrast to this, endothelial cells from NOS2-/- mice displayed an ex vivo NO 
production, which was comparable to the NO production as observed in the Control 
animals (NOS2-/- + LPS versus Control + LPS, n=3; P= 0.32; Fig. 37). 
Cu2FL2E –TPLSM imaging modality was used as the tool to investigate the role of arginine 
supplementation at sub-cellular level (structural-functional) during normal and 
endotoxemic condition in Arginase -/- mouse. 
The results indicate that extracellular arginine supplementation at basal level Argfl/fl/Tie2-
Cretg/- mice did not enhance NO signal in ECs and SMCs. The vasomotor response (i.e. 
the change in luminal diameter) indicates abrogation of NO production or its limited 
utilization for vasorelaxation as luminal diameter decrease (Fig. 37).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 38  Detection and quantification of NO produced in explanted murine arg -/- carotid 
arteries (endotoxemic) ex vivo using Cu2FL2E; NO signal detected in smooth muscle 
cells (SMCs) and endothelial cells (ECs) of the tissue with 5 min incubation of Cu2FL2E (20 
µM) and, subsequently 30min incubation of L-ARG (67 µM). Scale bars, 50 µm.  
SMC EC 
EC SMC 
- L-ARG 
- L-ARG + L-ARG 
+ L-ARG 
72 
 
 
                                                                                                                                         3. Results  
In contradiction, during ongoing endotoxemia (Argfl/fl/Tie2-Cretg/-+ LPS mice), L-arginine 
supplementation improved the localized NO production in both ECs (as seen by a 
significant increase in fluorescence intensity) and also the luminal diameter increased 
(Fig. 38) as seen from 3D constructions. The average luminal diameter of the 
endotoxemic arteries also increased (from; 165±10 µm, to; 195±10 µm) upon 
administration of arginine compared with normal arteries (from; 205±10 µm, to; 185±20 
µm). 
Modulating the arginase activity during endotoxemia needs to aim at restoring the 
balance between arginase and arginine supplementation during inflammatory 
conditions as this may be the key to an improved endothelial function. 
 
3.4.3 In vitro assessment of arginine supplementation on human coronary arterial 
endothelial cells 
Results indicate that arginine is immensely important for cell survival, as lack of arginine 
in medium in vitro leads to substantial cell death on shear stress-induced endothelial 
NO-production. On supplementation with 400 µM arginine, there is comparable cell 
survival and increased NO production. 
 
 
 
 
 
 
 
Fig. 39 Assessment of arginine supplementation on survival of HCAECs using Cu2FL2E; NO 
signal detected in endothelial cells (ECs) of the tissue with 5 min incubation of Cu2FL2E 
(20 µM) and, subsequently 30min incubation of L-ARG (67 µM). Scale bars, 50 µm.  
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3.5. In vitro thrombus imaging with carbon dot and TPLSM 
Application of novel fluorescent nanoparticle conjugated peptide in thrombus imaging 
using Two-Photon Laser Scanning Microscopy (TPLSM) is highlighted in this study. 
Experiments showed strong fluorescence (red) from TAMRA clearly showing the fibrin 
network. Initially, no fluorescence was seen from C-Dots. Later on increasing the power 
of the laser, the fluorescence from the TAMRA bleached and fluorescence (blue) from 
C-Dot tended to increase in the fibrin network. Hence, it was clear that fibrin was 
labeled by this bilabeled peptide. Fluorescence from the C-Dot can be seen in the blue 
range of spectra and therefore it can be used as an important fluorophore as not many 
fluorophores are known in this range. The surface chemistry of these cDots can also be 
used to tailor drugs and can be used to target various sites in vascular tree when 
conjugated with disease specific ligands in relation to various cardiovascular diseases 
like atherosclerosis, hypertension etc.  
 
3.5.1 Structure of the bi-labeled peptide 
Activated factor XIII (FXIIIa) plays an important role in regulating the resistance of 
thrombi against fibrinolysis. FXIIIa covalently crosslinks alpha2 antiplasmin, a key inhibitor 
of plasmin-mediated fibrinolysis, to fibrin.  
 
 
Fig. 40  Structure of A14 peptide conjugated with TAMRA (indicated with blue box) and 
C-dot (indicated with red circle) at the N-terminal of the peptide, showing proximity of 
C-dot and TAMRA conjugation on the peptide. 
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dot; A. at native state, B. c-dot 
conjugated A14 peptide, C. bilabeled 
peptide (c-dot & TAMRA conjugated 
with A14 peptide), showing effect of 
peptide and TAMRA conjugation on C-
Dot fluorescence response. 
                                                                                                                                         3. Results 
Factor XIII specific ligand (peptide A14) has been coupled to TAMRA (6-
carboxytetramethyl rhodamine dye) and cDot to visualize thrombus with two-photon 
microscopy (Fig. 40).  
 
3.5.2 Characterization of fluorescent properties of C-Dot 
Preliminary experiments were done with C-Dots using the Nanodrop photospectrometer 
to identify their fluorescence emission peaks. C-Dots were also used under two-photon 
microscopy to check their two-photon excitability. Additionally, their fluorescence 
lifetime was determined. Making use of surface chemistry of C-Dots, A14 peptide was 
prepared bilabeled with TAMRA (579nm emission) (RED) and C-Dot (439nm emission) 
(BLUE) to selectively target fibrin exposed on fresh thrombus in vitro.  
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Fig. 42 Fluorescence from 
C-dot expressed on fibrin; 
fluoresence from cDot 
expressed by slow 
photobleaching of TAMRA, 
A. TAMRA expressed on 
fibrin, B, C, D. cDot 
expression on fibrin 
 
                                                                                                                                         3. Results  
TAMRA is used as a control for cDot efficacy. Many experiments were performed using 
Nanodrop photosprctrometer to check the effect of peptide and TAMRA on cDot 
fluorescence emission (Fig. 41). Using two-photon microscopy the following two-photon 
fluorescent characteristics were revealed for c-dots: optimal excitation: 775nm, 
emission: 460-470nm, fluorescence lifetime: 2.7ns. 
 
3.5.3 Thrombus imaging with TPLSM and c-dot-TAMRA conjugated A14 peptide 
reveal c-dot and TAMRA as FRET pairs 
A14 peptide conjugated to carbon dots (cDots) was used to target fibrin exposed on 
fresh thrombus in vitro. A14 is an antiplasmin based peptide and its utility to image fresh 
thrombi has been shown before. Our experiment showed strong fluorescence (red) from 
TAMRA clearly showing the fibrin network. Initially, no fluorescence was seen from cDots 
(Fig. 42 (a). Later on increasing the power of the laser, the fluorescence from the TAMRA 
bleached and fluorescence (blue) from cDot tended to increase in the fibrin network 
(Fig. 42 (b, c, and d)].  
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Hence, it was clear that fibrin was labeled by this bilabeled peptide. This also shows FRET 
(Fluorescence Resonance Energy Transfer) on play. This can be further confirmed by 
measuring the change in fluorescence lifetime of C-Dot and TAMRA individually. C-Dot 
and TAMRA can also be used as an important FRET pair as seen from the experiment. 
Fluorescence from the C-Dot can be seen in blue range of spectra and therefore it can 
be used as an important fluorophore as not many fluorophores are known in this range. 
However, further experiments need to be done to validate the data. Since carbon dot 
shows promise as a labelling dye, further experiment must be done where C-Dot will be 
conjugated alone with the peptide and targeted to fresh thrombus. 
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4. General discussion - future perspectives 
The studies explore the feasibility of two-photon microscopy in unraveling structural and 
functional details in vasculature with high spatial and temporal resolution. Subcellular 
imaging from in vitro to ex vivo environment is addressed in the context of both nitric 
oxide imaging and thrombus imaging. 
In the first part, we demonstrate the feasibility of using Cu2FL2E as a direct, sensitive, and 
specific NO probe. Combined with TPLSM we describe a suitable imaging method for 
investigating NO biology in the vascular system.  
NO is an important messenger that regulates a multitude of physiological functions 
within the vascular system. Abrogation of NO production in case of dysfunctional 
endothelium can result in cardiovascular diseases such as hypertension, atherosclerosis 
and sepsis. To study its role and (sub) cellular constitution, direct and specific NO-
detection in living cells and tissues is a major requirement. The high diffusibility and short 
half-life of NO complicate real time detection. Several chemical methods are available 
to measure the oxidation products of NO, such as nitrite and nitrate, but detection of 
NO itself is still challenging. The lack of specific non-toxic NO probes has hampered the 
studies on important aspects of NO in cellular and tissue metabolism such as diffusion 
properties and depicting the exact source of NO production. In the present study, we 
establish the applicability of Cu2FL2E to analyze NO dynamics in cells and vasculature. 
Superior characteristics of Cu2FL2E such as non-toxicity, high specificity and sensitivity for 
NO make it an ideal probe. Cu2FL2E selectively detects NO over H2O2  (47), whereas 
DAF-2-DA failed to make this distinction (which is in agreement with literature (45, 78, 
118). Cu2FL2E also detects nanomolar concentrations of NO produced in vascular 
endothelial cells with higher sensitivity than DAF-2-DA. Based on the rate of NO 
generation from SNAP (1.4 µM NO per minute at a concentration of 100 µM in PBS at pH 
7.4 and 37oC) (114, 115), a rough estimate of the NO detection limit can be made. 
Under the conditions employed in our sensitivity test, in which both Cu2FL2E and DAF-2-
DA are challenged with various concentrations of SNAP, Cu2FL2E shows better sensitivity 
(significant change in fluorescence intensity with 2.5 µM of SNAP) by comparison to DAF-
2-DA (significant change with 5 µM of SNAP). By calculating back for NO concentration, 
the lower end detection limit of Cu2FL2E is ~35 nM, which is in the normal physiological  
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range of stimulated NO levels in healthy tissue. This calibration procedure gives an 
insight into semi-quantification of basal and accelerated levels of NO signal. Therefore, 
we believethat Cu2FL2E will also detect nanomolar concentrations of NO produced in 
vascular endothelial cells and arteries, which can be utilized in assaying NO contribution 
under normal and diseased conditions. We further show that ex vivo NO imaging in 
murine carotid arteries allows distinction of intimal (ECs) from medial (SMCs) NO signal. 
Although it is difficult to comment on the sources of NO generation and contribution, we 
speculate that ECs are the prime source of NO generation in the vessel wall (as                                                                                                                       
results show significant changes in fluorescence in ECs when triggered with flow or ACh), 
but the capacity of SMCs to generate NO (i.e. by activation of iNOS) (125, 126) must 
also be considered (specially, in case of chemical triggers like H2O2) and its limited 
capacity when induced by flow is interesting. Along with NO mediated vasodilation, 
endothelium-derived hyperpolarizing factor (EDHF) participation in relaxation of various 
arteries is another interesting aspect to study in this context. EDHF’s vasodilator action is 
of prime importance particularly when NO production is compromised. However, EDHF 
contribute mainly in small vessel dilation. Under our conditions, the carotids and aorta 
(with suitable controls) show vasorelaxation to be primarily NO-dependent. 
By obtaining NO occupancy profiles in SMCs and ECs, we specifically addressed 
compartments and temporal profiles of NO production in the vasculature. A similar 
profile was obtained with ACh stimulations (data not shown). The temporal occupancy 
profile of NO in different cells plays a major role in vascular biology and pathology, as 
that determines NO participation in protective or pathologic role.  
Quantitative differences in NO-signal ex vivo, as determined using Cu2FL2E, correspond 
with measurements of vasodilation or vasoconstriction, in the absence or presence of L-
NAME. This result not only establishes the viability of the mounted vessels, but also shows 
that Cu2FL2E does not affect the enzymatic activity of the NO synthesis or of 
downstream pathways involved in SMC-relaxation. Thus, the use of Cu2FL2E in 
combination with TPLSM (resolution and penetration depth) and mounting the arteries in 
the vessel chambers is a valuable method to analyze NO in vascular tissue with high 
specificity and cellular resolution.  
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SNAP has been used by multiple investigators as one of the most widely used chemical 
sources for NO since there is no authentic stable source for NO (46, 114, 115, 127). SNAP 
releases NO and other thiyl molecules almost instantaneously, at controlled rate (128). In 
contrast, for short time experiments, NONOates are not a suitable choice because of 
their slow dissociation rate, while solutions of NO can dissociate before reaching the 
probe. We evaluated the effect of SNAP on vascular endothelial cells loaded with 
probe, to check if on removal of SNAP the fluorescence of the probe is affected or not. 
A point of consideration in this study is the role of the Cu(II)/Cu(I) ion on NO release from 
S-nitrosothiols (SNAP) or by cells associated with activated eNOS. According to previous 
studies (115, 127), copper ions can decompose S-nitrosothiols more rapidly, thus 
speeding up NO release from SNAP. Therefore, we evaluated the influence of the 
copper ions on the release of NO from SNAP. 
We found that the fluorescence response of DAF to NO (delivered by SNAP) in the 
presence of similar amounts of CuCl2 as present in Cu2FL2E did not change significantly. 
This result confirmed that there is no measurable influence of copper under the 
experimental conditions used in our studies. Use of copper chelators, NO scavengers 
and EPR measurement have already been shown by Lim et al (46) that confirmed no 
influence of copper in the measurements. However, we cannot completely exclude the 
possibility that fluorescence increase in stimulated cells results from activated eNOS was 
due to presence of copper-ions along with extracellular calcium (128). Nevertheless, 
control experiments, such as cells incubated with Cu2FL2E, without stimulus did not 
exhibit significant fluorescence, indicating that Cu(I)/Cu(II) ions by themselves do not 
interfere with cellular NO imaging. In cells, copper released from Cu2FL2E is likely 
scavenged rapidly by cellular components such as metallothionein or copper 
chaperones, minimizing the chance of copper ions to influence the cellular response. 
An intriguing question still to be answered concerns the contribution of subclasses NO 
synthases (NOS) to the total NO production in healthy and diseased vessels. This 
experimental methodology opens new avenues for further research on NO metabolism 
and its effect on vessel wall morphology and function. Direct visualization and 
measurement of NO would help to further elucidate its role as an important determinant 
of endothelium dysfunction in relation to diseases like atherosclerosis and hypertension.  
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In this study, we have used healthy blood vessels and ECs in the absence of 
cardiovascular risk factors. With more complex morphology of the vessel wall as in an 
atherosclerotic lesion, visualization of NO is even more important. 
In conclusion, NO analysis with Cu2FL2E in combination with TPLSM allows specific 
detection and semi-quantification of endogenous NO production both in vitro and ex 
vivo with high spatial-temporal resolution.  With the use of Cu2FL2E and TPLSM we are 
able to unravel the structural-functional relationship of NO in the vessel wall. The 
presence of NO in various vascular cells could be monitored ex vivo for several 
physiological NO-stimuli. The presented analytical method for temporal-spatial kinetics 
of NO synthesis and the presence in the vascular wall provides a valid method to study 
the role of NO in vascular biology at an unprecedented level. Thus, the findings of this 
research hold key for future research and application in the field of basic medical 
biology. 
In line with this study, Cu2FL2E-TPLSM method was further applied to study modulated 
NO formation in endotoxemia. In this study, a newly developed prolonged murine 
endotoxemia model was used to investigate the disturbances of the arginine-NO 
metabolism and to investigate the role of L-arginine supplementation during ongoing 
endotoxemia. The results of the present investigation, in the second part, demonstrated 
that endothelial capacity to produce NO is restored by L-arginine supplementation in a 
prolonged murine endotoxemia model. However, its effect for microcirculatory 
improvement needs to be studied and validated. Finding ways to prevent or reverse 
endothelial activation can help reduce vascular complications. Also, investigation of 
endothelial specific arginase I deficiency in a prolonged in vivo model of murine 
endotoxemia by Cu2FL2E-TPLSM demonstrated an enhanced NO production. Our 
findings reveal that the enhanced NO production was NOS2 derived in endothelial cells 
and tissue.  
As seen from the results, the enhanced plasma arginine availability due to deficiency of 
arginase 1, did not influence the basal NO production. Thus, during basal conditions, 
enhanced plasma L-arginine availability did not influence the NOS3 derived NO  
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production. In addition, an experimental L-arginine deficient state (86, 87) was used to 
determine the role of the tissue specific arginase-I on NOS3 derived NO.  
LPS infusion in the Argfl/fl/Tie2-Cretg/- mice resulted in a significant increased NO 
production in endothelial cells. Since the remnant arginase-I activity in these tissue 
specific Argfl/fl/Tie2-Cretg/- mice is negligible, another important competitor for arginine 
availability may benefit from the arginase I deficiency instead of NOS3. The impaired 
inhibition of NOS2 activity, by arginase-I, is suggested to play the leading part in the 
detrimental outcome of this study. Normally, arginase-I competes with NOS2 for 
substrate (105, 129, 130) and regulates the NOS2 translation and expression, especially in 
the endothelium, which restrains the inflammatory response (131).  This knowledge led to 
investigate whether in vivo NOS2 inhibition would positively influence the NO production 
and microcirculation. In vivo suppression of NOS2 with 1400W revealed lower tissue 
(endothelial cells) NO production, suggesting the enhanced NO production to be NOS2 
derived in the Argfl/fl/Tie2-Cretg/-mice. Endothelial / hematopoetic arginase-I deficient 
(Argfl/fl/Tie2-Cretg/-) knock-out mice exhibited an enhanced by an enhanced NO 
production in endothelial cells under basal and endotoxemic conditions. Selective 
NOS2 inhibition in endotoxemic Argfl/fl/Tie2-Cretg/- mice prevented the enhanced 
inflammatory response and NO production, which strengthened our findings, that NOS2 
benefits from the arginase-I tissue specific deficiency during endotoxemia. 
In conclusion, arginase I plays a crucial role in controlling NOS2 during inflammation in 
endothelial cells, and modulating the arginase activity during endotoxemia needs to be 
performed with great precautions. 
Therefore, future studies need to focus on the fragile balance between arginase and 
NOS2 during inflammatory conditions as this may be the key to an improved endothelial 
function. 
In the final part, we presented work on CDots conjugated peptide that can affordably 
image thrombus formation. In this study, an alpha2-antiplasmin based peptide was used 
conjugated with C-Dot (as a fluorescent marker) to visualize early stage of thrombus 
formation. Activated factor XIII (FXIIIa) covalently crosslinks alpha2-antiplasmin to fibrin in 
early stage thrombus. Thus, in vitro generated thrombi were targeted with this new  
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conjugated agent to visualize fibrins expressed on fresh thrombus. With very interesting 
set of experiments, binding of this agent to fresh thrombi were observed. TAMRA and C-
Dot evolved to be FRET pairs from our experiment, and a novel biomarking strategy was 
developed. A challenge for biomarking, based on luminescent materials, has been the 
development of structures (C-Dot) with highly visible emissions for precise imaging, 
combined with nanoscale dimensions for suitable targetting. 
The surface chemistry of these CDots can also be used to tailor drugs and can be used 
to target various sites in vascular tree when conjugated with disease specific ligands. 
This will prove its importance in clinical platform as it will not only help in imaging but 
drugs attached to it will help to resist the progression of disease. It can also be used to 
target atherosclerotic plaques. Biodistribution study of this CDot peptide in mice needs 
to be optimized for assessing its binding capabilities and it will also show the 
biocompatibility of the conjugate in the body or if it induces certain other reponses. The 
most important use of this CDot peptide conjugate in comparison to qdot-peptide 
conjugate is that it increases the time window during which this can be used for 
thrombus detection as CDot is resistant to photobleaching and photoblinking. The CDot 
peptide conjugate prepared here specifically binds to fibrin expressed on fresh 
thrombus. Using the surface chemistry of the CDots other peptide could be tagged that 
specifically binds to receptors expressed on organized (old) thrombus. Alpha 2b beta 3 
integrin receptor expressed in platelet on an organized thrombus may be targeted and 
imaged. This will help in a comparative analysis of thrombi using CDot – peptide 
conjugate. In vivo imaging is another possible exploration of this method to image 
thrombus. The surface chemistry of CDots also gives option to attach Gd-complexes so 
that it can be used as bimodal agents in fluorescence imaging and in MRI. 
Determination of the optimal dosage is another important study that needs to be 
standardized.  
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5. Summary 
The domain of the vascular biology is a complex system consisting of different types of 
blood vessels, cells, and signaling molecules. It is now recognized that these vessels and 
molecules are part of a subtle regulatory system with differential properties along the 
vascular tree. Altered production of these molecules is a molecular clue for 
dysfunctionality of cells or alterations of vessel properties that may lead to various acute 
and chronic diseases. Current knowledge of such vascular alterations is mostly based on 
histological studies of isolated samples that have lost their viability. Functional properties 
of various compounds are still largely unknown. Better understanding of the functionality 
of these molecules in the context of cardiovascular functioning can increase insight in 
early stage of disease condition. Thus studying these properties in vivo or in viable 
arteries ex vivo is indispensable. This thesis focuses on the vessel wall of large murine 
arteries and cultured cell systems using TPLSM as an imaging tool for studying alterations 
in vessel wall properties as well as important molecules and their functional 
consequences. 
In this thesis, I first addressed the concept of NO imaging in vasculature with a novel 
method. Nitric oxide analysis with Cu2FL2E in combination with TPLSM allowed specific 
detection and semi-quantification of endogenous NO production both in vitro and ex 
vivo. With the use of Cu2FL2 and TPLSM we were able to unravel the structural-functional 
relationship of NO in the vessel wall. Presence of NO in various vascular cells could be 
monitored ex vivo for several physiological NO-stimuli. The Cu2FL2E-TPLSM approach 
provides a valid method to study the role of NO in vascular biology at an 
unprecedented level and can enable investigation of the regulatory pathways in the 
complex interplay between NO and vascular (dys)function. 
In the second part, NO production was studied with TPLSM in murine endotoxemia. 
Impact of arginine supplementation in wild type and ARG-1 -/- mouse, in NO metabolism 
was investigated. A disturbed arginine-nitric oxide metabolism is associated with 
endotoxemia. Therefore, the effect of L-arginine supplementation on eNOS-induced 
intracellular NO production was studied in wild type and a non-lethal prolonged 
endotoxemia model in mice. TPLSM revealed that the L-arginine supplementation 
restored intracellular NO production during endotoxemia. 
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However, further investigation is needed to find out if this NO improves the 
microcirculation during endotoxemia. Arginase-I also contributes to endothelial 
dysfunction during endotoxemia as it competes with NOS3 for arginine availability. 
Therefore, I investigated the effects of cell-specific arginase-1 deficiency on the arginine 
availability, the NOS3-derived NO production during murine endotoxemia.  Arginase-I 
plays a crucial role in controlling NOS2 during inflammation in endothelial cells. 
Modulating the arginase activity resulted in an inflammatory response an increased NO 
production by NOS2. Therefore, modulating  arginase activity during endotoxemia 
needs to aim at restoring the balance between arginase and NOS2 during inflammatory 
conditions, as this may be the key to an improved endothelial function. 
 
In the final part, visualization of fresh thrombus formation has been described using 
fibrin-targeted peptide conjugated with C-Dot. Thrombosis plays a major role in several 
vascular diseases and early detection of thrombus formation is a hitherto unmet 
requirement in clinical practice. Further validation of this method might help in 
translation of early detection strategy of thrombus in clinical scenario. 
 
In general discussion, I contemplate various ideas regarding the topics described and 
open new avenues and possible future outcomes for application of these novel studies. 
I conclude that the described techniques (in the forefront of TPLSM imaging) offer a 
new and different view on healthy and diseased arteries and provide new insight in 
various structural and functional properties of vessels. Further development of these 
techniques holds potential for future applications in both a scientific and clinical 
environment. 
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6. Zusammenfassung 
Das Gebiet der Gefäßbiologie ist ein komplexes System, bestehend aus verschiedenen 
Typen von Blutgefäßen, Zellen und Signalmolekülen. Diese Gefäße und Moleküle  sind 
Teil eines subtilen regulatorischen Systems mit verschiedenen Eigenschaften. Eine 
Störung der Produktion dieser Moleküle ist der Initiator von Dysfunktionalität von Zellen 
oder Veränderungen der Blutgefäßeigenschaften, die zu verschiedenen akuten und 
chronischen Erkrankungen führen können. Derzeitige Erkenntnisse solcher 
Gefäßveränderungen basieren vor allem auf histologischen Studien von isolierten 
Gewebeproben, welche durch die verschiedenen Fixierungsmethoden ihre 
Lebensfähigkeit verloren haben. Die funktionellen Eigenschaften der verschiedenen 
Stoffe noch weitgehend unbekannt. Ein besseres Verständnis der Funktion dieser 
Moleküle im Bezug auf die Herz-Kreislauf-Funktionen können einen besseren Einblick in 
das frühe Stadium der Krankheitszustand ermöglichen. Somit sind diesbezügliche Studien 
in vivo oder in lebensfähigen Arterien ex vivo ist unverzichtbar. Diese Arbeit konzentriert 
sich auf die Gefäßwand von murinen Hauptarterien und in vitro kultivierten Zellsystemen 
mit TPLSM als Bildgebungsmethode, um die Veränderung der Gefäßwandeigenschaften 
sowie wichtige Moleküle und deren funktionelle Konsequenzen zu untersuchen. 
In dieser Arbeit visualisieren ich Stickstoffmonoxid (NO) in Gefäßen mit einem neuartigen 
Verfahren. Stickoxid-Analyse mit Cu2FL2E in Kombination mit TPLSM erlaubt den 
spezifischen Nachweis und semi-Quantifizierung der endogenen NO-Produktion in vitro 
und ex vivo. Durch den Einsatz von Cu2FL2 und TPLSM konnten wir den strukturellen und 
funktionalen Einfluss von NO in der Gefäßwand entwirren. Die Anwesenheit von NO in 
verschiedenen vaskulären Zellen konnte ex vivo für mehrere physiologische NO-Reize 
beobachtet werden. Der Cu2FL2E-TPLSM Ansatz bietet eine passende Methode, um die 
Rolle von NO in der vaskulären Biologie zu studieren und ermöglicht die Untersuchung 
der Regulationsmechanismen in dem komplexen Zusammenspiel zwischen NO und 
vaskuläre (Dys)-Funktion. 
Im zweiten Teil wurde die NO-Produktion in Mäuse mit Endotoxinämie mittels TPLSM 
untersucht. Auswirkungen von Arginin im NO-Metabolismus wurde in Wildtyp und ARG -1 
-/- Mäuse untersucht. Ein gestörter Arginin-Stickstoffmonoxid Stoffwechsel ist mit  
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Endotoxinämie verbunden. Aus diesem Grund wurde die Wirkung von L-Arginin Zusatz 
auf eNOS-induzierte intrazelluläre NO-Produktion in Wildtyp und nicht-tödliche 
verlängerte Endotoxämie in Mäusen untersucht. TPLSM zeigte, dass L-Arginin Zusatz bei 
Endotoxinämie die intrazellulären NO-Produktion wiederherstellte. Allerdings sind weitere 
Untersuchungen erforderlich, um zu zeigen ob NO die Mikrozirkulation bei 
Endotoxinämie verbessert. Arginase-I trägt auch zu einer endothelialen Dysfunktion bei 
Endotoxinämie bei, da es mit NOS3 um Arginin konkurriert. Wir haben daher die 
Auswirkungen des zellspezifischen Arginase-1-Mangels im Bezug auf die Arginin 
Verfügbarkeit untersucht und die NOS3-abhängige NO-Produktion während der 
murinen Endotoxinämie. Arginase-I spielt eine entscheidende Rolle bei der Regulierung 
von NOS2 während der Entzündung in Endothelzellen. Die Veränderung der 
Arginaseaktivität führte zu einer Entzündungsreaktion und einer erhöhten NO-Produktion 
durch NOS2. Daher muss die Steuerung der Arginase-Aktivität unter entzündlichen 
Bedingungen während Endotoxinämie gezielt auf die Wiederherstellung des 
Gleichgewichts zwischen Arginase und NOS2 zielen, da dies der Schlüssel zu 
verbesserten Endothelfunktion sein kann. 
Im letzten Teil wird die Visualisierung von Thrombusbildung durch ein Fibrin-spezifisches 
Peptid konjugiert mit C-Dots beschrieben. Thrombose spielt eine wichtige Rolle in 
verschiedenen Gefäßerkrankungen und die Früherkennung von Thrombusbildung ist ein 
bisher unerfüllten Anforderungen in der klinischen Praxis. Weitere Untersuchungen und 
Validierung dieser Methode könnte der Translation dieser Thrombus-
Früherkennungsstrategie in klinischen Szenarios helfen. 
In der allgemeinen Diskussion betrachten wir verschiedene Ideen über die Themen 
beschrieben und eröffnen neue Möglichkeiten, zukünftige Ergebnisse für die 
Anwendung dieser neuartigen Studien. Wir schlussfolgern, dass die beschriebenen 
Techniken (in vorderster Front TPLSM imaging) einen neuen und anderen Blick auf 
gesunden und kranken Arterien bietet und neue Einblicke in den verschiedenen 
strukturellen und funktionellen Eigenschaften von Blutgefäßen. Die Weiterentwicklung 
dieser Techniken hat Potential für zukünftige Anwendungen in sowohl einer 
wissenschaftlichen als auch  klinischen Umfeld. 
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